: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription

Articles published in Ann Surg Oncol
Retrieve available abstracts of 719 articles:
HTML format

Single Articles

June 2026

HAGER MG, Hoskin TL, Ruddy KJ, Boughey JC, et al
ASO Visual Abstract: Utility of 21-Gene Recurrence Score in Male Breast Cancer.
Ann Surg Oncol. 2026 Jun 4. doi: 10.1245/s10434-026-19868.
PubMed

KALLES V, Mitrousias A, Vlachogiorgos A, Toesca A, et al
ASO Author Reflections: Enhancing Technical Reproducibility and Ergonomics in Single-Port Endoscopic Nipple-Sparing Mastectomy.
Ann Surg Oncol. 2026;33:5620-5621.
PubMed Abstract available

KALLES V, Mitrousias A, Vlachogiorgos A, Tsoti SM, et al
Single-Port Endoscopic Nipple-Sparing Mastectomy Using a Handheld Motorized Articulating System: Technical Description and Initial Outcomes.
Ann Surg Oncol. 2026;33:5606-5607.
PubMed Abstract available

SCARDINA L, D'Archi S, Accetta C, Carnassale B, et al
Axillary Nodal Positivity in Early-Stage Invasive Lobular Carcinoma: Implications for Sentinel Lymph Node Biopsy Omission.
Ann Surg Oncol. 2026;33:5598-5605.
PubMed Abstract available

MASHAL S, Melanson A, Apostolova C, Ferroum A, et al
Impact of Ethnicity on the Uptake of Risk Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.
Ann Surg Oncol. 2026;33:5590-5597.
PubMed Abstract available

YOON J, Lee SB, Kim J, Chung IY, et al
Omitting Axillary Surgery in Patients with Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery.
Ann Surg Oncol. 2026;33:5574-5580.
PubMed Abstract available

HOLT L, Chamberlain V, Shern T, Gadd MA, et al
Risk Stratification of Fibroepithelial Breast Lesions: Clinical and Ultrasound Features Associated with Fibroadenoma and Phyllodes Tumors.
Ann Surg Oncol. 2026;33:5567-5573.
PubMed Abstract available

QU FL, Cheng JY, Jiang SH, Zhang Q, et al
Omission of Axillary Surgery in Patients with Negative Axillary Evaluation Integrated with LymphPET: A Prospective Clinical Study.
Ann Surg Oncol. 2026;33:5558-5566.
PubMed Abstract available

CHOI JE, Lee YW, Gwark S, Paek SH, et al
Single-Port Robot-Assisted Nipple-Sparing Mastectomy: Main Analysis of a Retrospective Multicenter Study (SPROUT, KoREa-BSG 09).
Ann Surg Oncol. 2026;33:5533-5540.
PubMed Abstract available

GIANMATTEO P, Andrea P, Erica AA, Antuono L, et al
RADar Reflector LocalisatIOn-SCOUT((R)) for CarcinOma Mammae, a Prospective Observational Study Sharing Clinical Experience at the European Institute of Oncology in Milan: RADIOSO Milan Trial.
Ann Surg Oncol. 2026;33:5513-5523.
PubMed Abstract available

May 2026

LI K, Zhang Y, Liu Z, Wang S, et al
ASO Visual Abstract: Global Inequalities in Female Breast Cancer Burden by Decomposition and Age-Period-Cohort Analysis, 1990-2021.
Ann Surg Oncol. 2026 May 30. doi: 10.1245/s10434-026-19883.
PubMed

STANCZYK M, Cheung TC, Lang JE
The Past, Present, and Future of Sentinel Lymph Node Biopsy in Breast Cancer.
Ann Surg Oncol. 2026 May 29. doi: 10.1245/s10434-026-19672.
PubMed Abstract available

WANIS KN, Krasniqi R, Sun SX, Resetkova E, et al
ASO Visual Abstract: Sentinel Lymph Node Positivity and Utility of Frozen Section Diagnosis After Neoadjuvant Therapy for Patients with Clinically Node-Negative Hormone Receptor-Positive, HER2-Negative Breast Cancer.
Ann Surg Oncol. 2026 May 26. doi: 10.1245/s10434-026-19872.
PubMed

PETRELLI F, Pavesi V, Mercurio P, Burgoa L, et al
Leaving the Axilla Untouched: Toward Surgical De-escalation in Early Luminal A Breast Cancer.
Ann Surg Oncol. 2026 May 20. doi: 10.1245/s10434-026-19836.
PubMed

WANIS KN, Krasniqi R, Sun SX, Resetkova E, et al
Sentinel Lymph Node Positivity and Utility of Frozen Section Diagnosis following Neoadjuvant Therapy in Patients with Clinically Node-Negative, Hormone Receptor-Positive, HER2-Negative Breast Cancer.
Ann Surg Oncol. 2026 May 14. doi: 10.1245/s10434-026-19783.
PubMed Abstract available

RODRIGUEZ L, Wu R, Kassi A, Ishikawa T, et al
ASO Visual Abstract: High PARP7 Expression is Associated with Higher Estrogen Response and Immune Suppression but Less Cell Proliferation and Better Survival in Breast Cancer.
Ann Surg Oncol. 2026 May 11. doi: 10.1245/s10434-026-19789.
PubMed

HAGER MG, Hoskin TL, Ruddy KJ, Boughey JC, et al
Utility of 21-Gene Recurrence Score in Male Breast Cancer.
Ann Surg Oncol. 2026 May 11. doi: 10.1245/s10434-026-19779.
PubMed Abstract available

GRAHAM-STEPHENSON A, Fanning CE, Geven EL, Migyanka F, et al
ASO Visual Abstract: Geographic Differences in Patient Experience after a Diagnosis of Lobular Breast Cancer.
Ann Surg Oncol. 2026 May 7. doi: 10.1245/s10434-026-19635.
PubMed

MULLER M, Heil J, Pfob A, Cai L, et al
Predictive Value of Routine Imaging for the Diagnosis of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
Ann Surg Oncol. 2026 May 4. doi: 10.1245/s10434-026-19670.
PubMed Abstract available

SIDIROPOULOU Z
The Superficial (Anterior) Plane in Mastectomy: An Under-Measured Margin Variable with Implications for Local Recurrence.
Ann Surg Oncol. 2026;33:4648-4649.
PubMed Abstract available

LLOYD K, Shern TP, Holt LR, Daly AE, et al
Outpatient Mastectomy with Reconstruction at Ambulatory Surgery Centers.
Ann Surg Oncol. 2026;33:4573-4583.
PubMed Abstract available

CHANDRAN T, Wager JL, Obeid K, Baker J, et al
Does Multidisciplinary Clinic Impact Rates of Breast Conserving Therapy?
Ann Surg Oncol. 2026;33:4555-4562.
PubMed Abstract available

CUILLERIER NJS, Almarzooqi H, Villareal-Corpuz V, Sabboobeh S, et al
Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen.
Ann Surg Oncol. 2026;33:4510-4517.
PubMed Abstract available

HOLT L, Chamberlain V, Shern T, Abir FF, et al
AI-FLEET: Phase I-Multimodal Deep Learning Model for Phyllodes Tumor Classification.
Ann Surg Oncol. 2026;33:4503-4509.
PubMed Abstract available

TAYLOR ND, Rezo A, Majeed U, He YM, et al
Impact of Anterior Margin Status Following Skin- or Nipple-Sparing Mastectomy in Patients Undergoing Implant-Based Breast Reconstruction.
Ann Surg Oncol. 2026;33:4494-4502.
PubMed Abstract available

MASANAM MK, Kantor O, Pappas Brunco O, Faust AC, et al
Evaluating the Impact of a Surgeon-Led Ductal Carcinoma in Situ Program on Endocrine Therapy Uptake.
Ann Surg Oncol. 2026;33:4463-4471.
PubMed Abstract available

GARCIA DI, Daly AE, Anderman KJ, Holt LR, et al
Bracketed Lumpectomy: A Comparison of Radiofrequency Identification Tag Localization to Wire Localization.
Ann Surg Oncol. 2026;33:4407-4416.
PubMed Abstract available

April 2026

CHIDA K, Wu R, Kawashima K, Grapes A, et al
ASO Visual Abstract: Ki67 Gene Expression is Associated with Immune Cell Infiltration and Neoadjuvant Chemotherapy Response in ER+/HER2- Breast Cancer.
Ann Surg Oncol. 2026 Apr 28. doi: 10.1245/s10434-026-19705.
PubMed

MULLER M, Heil J, Pfob A, Cai L, et al
ASO Visual Abstract: Predictive Value of Routine Imaging for the Diagnosis of Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
Ann Surg Oncol. 2026 Apr 28. doi: 10.1245/s10434-026-19723.
PubMed

CHIDA K, Wu R, Kawashima K, Grapes A, et al
ASO Author Reflections: Does Ki67 Gene Expression Capture Immune Infiltration and Predict Chemotherapy Response in ER+/HER2- Breast Cancer?
Ann Surg Oncol. 2026 Apr 27. doi: 10.1245/s10434-026-19720.
PubMed

CHEN JH, Wanis KN, Rahman M, Gianchandani A, et al
ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.
Ann Surg Oncol. 2026 Apr 22. doi: 10.1245/s10434-026-19661.
PubMed

SARIDEMIR S, Guler OC, Dincer B, Karayigit A, et al
Axillary Pathologic Complete Response as a Stronger Prognostic Marker than Breast pCR in Clinically Node-Positive Stage II-III Breast Cancer.
Ann Surg Oncol. 2026 Apr 19. doi: 10.1245/s10434-026-19630.
PubMed Abstract available

LEE YR, Giannakeas V, Narod SA, Lim DW, et al
Association Between Tumor Size and Nodal Positivity for HER2+ and Triple-Negative Early-Stage Breast Cancer: A Population-Based Study.
Ann Surg Oncol. 2026 Apr 19. doi: 10.1245/s10434-026-19581.
PubMed Abstract available

LEE YR, Giannakeas V, Narod SA, Lim DW, et al
ASO Visual Abstract: Association Between Tumor Size and Nodal Positivity for HER2+ and Triple-Negative Early-Stage Breast Cancer: A Population-Based Study.
Ann Surg Oncol. 2026 Apr 17. doi: 10.1245/s10434-026-19659.
PubMed

WANG J, Chen J, Amburn T, Wagner BD, et al
ASO Visual Abstract: Axillary Lymph Node Dissection Through a Separate Incision Does Not Increase Rates of Breast Cancer-Related Lymphedema.
Ann Surg Oncol. 2026 Apr 17. doi: 10.1245/s10434-026-19367.
PubMed

SHERN TP, Holt LR, Lloyd K, Daly AE, et al
ASO Visual Abstract: Economic and Health System Impact of Implementing the SOUND Trial Approach in Early-Stage Breast Cancer.
Ann Surg Oncol. 2026 Apr 16. doi: 10.1245/s10434-026-19657.
PubMed

SHAH A, Love JA, Butler M, Butler LN, et al
ASO Visual Abstract: Integrating Generative AI into Nomograms for Breast Cancer Nodal Risk Predictions.
Ann Surg Oncol. 2026 Apr 15. doi: 10.1245/s10434-026-19605.
PubMed

CHIDA K, Wu R, Kawashima K, Grapes A, et al
Ki67 Gene Expression is Associated with Immune Cell Infiltration and Neoadjuvant Chemotherapy Response in ER+/HER2- Breast Cancer.
Ann Surg Oncol. 2026 Apr 10. doi: 10.1245/s10434-026-19620.
PubMed Abstract available

HANNOUN-LEVI JM, Kirova Y
Re-irradiation for Second Ipsilateral Breast Cancer Event: Is There Any Debate?
Ann Surg Oncol. 2026 Apr 10. doi: 10.1245/s10434-026-19584.
PubMed

CHEN JH, Wanis KN, Rahman M, Gianchandani A, et al
Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.
Ann Surg Oncol. 2026 Apr 8. doi: 10.1245/s10434-026-19588.
PubMed Abstract available

MONTAGNA G, Weber WP, Morrow M, Sevilimedu V, et al
Letter to the Editor Regarding Abdulla, H.A., et al. "Oncologic Outcomes of Sentinel Lymph Node Biopsy Versus Targeted Axillary Dissection for Node-Positive Breast Cancer Patients After Neoadjuvant Chemotherapy: A Systematic Review and Meta-analysis".
Ann Surg Oncol. 2026 Apr 5. doi: 10.1245/s10434-026-19602.
PubMed

BOCCARDO F
ASO Author Reflections: LYMPHA for Prevention of Breast Cancer-Related Lymphedema: Long-Term Evidence from a 15-Year Follow-Up.
Ann Surg Oncol. 2026 Apr 5. doi: 10.1245/s10434-026-19596.
PubMed

ABDULLA HA, McGarry J, Prichard RS, Boland MR, et al
Reply to: "Letter to the Editor Regarding Abdulla HA, McGarry J, Kaczorowska R, et al. Oncologic Outcomes of Sentinel Lymph Node Biopsy Versus Targeted Axillary Dissection for Node-Positive Breast Cancer Patients After Neoadjuvant Chemotherapy: A Syst
Ann Surg Oncol. 2026 Apr 3. doi: 10.1245/s10434-026-19615.
PubMed

STONEBANKS CUILLERIER NJ, Wong SM
Reply to "Beyond Uptake Aligning Low-Dose Tamoxifen Adherence with Absolute Breast Cancer Risk," by Hu, Zhiping et al.
Ann Surg Oncol. 2026 Apr 2. doi: 10.1245/s10434-026-19525.
PubMed

JUNG JJ, Kim HK, Kang E, Park EK, et al
ASO Visual Abstract: Enhancing Early Detection of Contralateral Breast Cancer in Breast Cancer Survivors Using AI-Assisted Mammography.
Ann Surg Oncol. 2026 Apr 2. doi: 10.1245/s10434-026-19535.
PubMed

VETTER CD, Boughey JC, Johnson JE
Cost-Effectiveness Analysis of Axillary Management Options at the Time of Contralateral Prophylactic Mastectomy.
Ann Surg Oncol. 2026;33:3273-3282.
PubMed Abstract available

MORTON CR, Chen YJ, Williams K, Bloch RA, et al
Efficiency of Sorting Site of Care for Frail Patients Undergoing Mastectomy.
Ann Surg Oncol. 2026;33:3319-3326.
PubMed Abstract available

MRDUTT MM, Day CN, Madrigrano A, Boughey JC, et al
ALND Experience During Breast Surgical Oncology Fellowship over the Years: An SSO/ASBrS Collaborative Analysis.
Ann Surg Oncol. 2026;33:3414-3420.
PubMed Abstract available

GAILLARD T, Beddok A, Baadj Y, Feron JG, et al
Outcomes of Second Breast-Conserving Surgery Without Reirradiation for Breast Tumor Recurrence.
Ann Surg Oncol. 2026;33:3364-3373.
PubMed Abstract available

SHAO Y, Wang X, Yang J, Huang Y, et al
From Proteomics to Pathology: S100A8's Impact on Breast Phyllodes Tumors Grading.
Ann Surg Oncol. 2026;33:3651-3665.
PubMed Abstract available

LEONARD L, Yi M, Wingate E, Singh P, et al
Axillary Management after Neoadjuvant Endocrine Therapy (NET).
Ann Surg Oncol. 2026;33:3327-3337.
PubMed Abstract available

NAKADAIRA U, Sakai T, Ogiya A, Inoue Y, et al
Feasibility of Omitting Axillary Dissection after Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence: A Single-Center Retrospective Study.
Ann Surg Oncol. 2026;33:3338-3344.
PubMed Abstract available

DONICA WRF, Shartzer DS, Ramakrishnan VG, Kuhl E, et al
External Validation of a Pragmatic Scoring System for Predicting Upgrade of Atypical Ductal Hyperplasia at the Time of Surgery.
Ann Surg Oncol. 2026;33:3283-3292.
PubMed Abstract available

KIM J, Park C, Jeon BJ, Pyon JK, et al
Complication Profiles of Immediate Implant-Based versus Deep Inferior Epigastric Perforator Flap Breast Reconstruction following Nipple/Skin-Sparing Mastectomy in Patients with Prior Breast-Conserving Surgery and Radiotherapy.
Ann Surg Oncol. 2026;33:3056-3065.
PubMed Abstract available

TOUADI M, Ross S, Sucandy I
Robotic Partial Central Hepatectomy for Juxtahilar Tumor: Technique of Middle Hepatic Vein Tangential Reconstruction.
Ann Surg Oncol. 2026;33:2926-2927.
PubMed Abstract available

KAUR S, Gastman B, Broderick KP, Momoh AO, et al
Antibiotics and Surgical Site Infection in Expander-Based Breast Reconstruction Trial (ASSERT).
Ann Surg Oncol. 2026;33:3033-3044.
PubMed Abstract available

March 2026

GRAHAM-STEPHENSON A, Fanning CE, Geven EL, Migyanka F, et al
Geographic Differences in Patient Experience After a Diagnosis of Lobular Breast Cancer.
Ann Surg Oncol. 2026 Mar 31. doi: 10.1245/s10434-026-19523.
PubMed Abstract available

GALLAGHER K, Feldman S, Barone J, Mammen J, et al
ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer.
Ann Surg Oncol. 2026 Mar 30. doi: 10.1245/s10434-026-19402.
PubMed

SHERN TP, Holt LR, Lloyd K, Daly AE, et al
Economic and Health System Impact of Implementing the SOUND Trial Approach in Early-Stage Breast Cancer.
Ann Surg Oncol. 2026 Mar 30. doi: 10.1245/s10434-026-19564.
PubMed Abstract available

HU Z, Gu X, Fu H
Beyond Uptake: Aligning Low-Dose Tamoxifen Adherence with Absolute Breast Cancer Risk.
Ann Surg Oncol. 2026 Mar 30. doi: 10.1245/s10434-026-19521.
PubMed

BOCCARDO F, Santori G, Fedre B, Fregatti P, et al
LYMPHA Technique to Prevent Arm Lymphedema After Breast Cancer Treatment: A Single-Center Study Based on a 15-Year Follow-Up Period.
Ann Surg Oncol. 2026 Mar 26. doi: 10.1245/s10434-026-19526.
PubMed Abstract available

WRIGHT GP, Thompson JL
ASO Author Reflections: Reexamining Physical Examination in Modern Breast Cancer Survivorship.
Ann Surg Oncol. 2026 Mar 23. doi: 10.1245/s10434-026-19399.
PubMed

MENEVEAU MO, Sevilimedu V, Le T, Eskreis-Winkler S, et al
I?s Neoadjuvant Chemotherapy Justified When Triple-Negative Breast Cancer or HER2-Positive Breast Cancer Presents as >/=1 cm of Only Calcifications or as a Subcentimeter Mass with Surrounding Calcification?s?
Ann Surg Oncol. 2026 Mar 22. doi: 10.1245/s10434-026-19475.
PubMed Abstract available

DIMAANO K, Castillo O Jr, Moazzez A, Ozao-Choy J, et al
ASO Visual Abstract: Examining the Representation of Minority Race and Ethnicity Groups in Breast Cancer Clinical Trials in the United States Published 2012-2022.
Ann Surg Oncol. 2026 Mar 17. doi: 10.1245/s10434-026-19368.
PubMed

SCHRANK Z, Landrum K, Agala CB, Gallagher KK, et al
Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.
Ann Surg Oncol. 2026 Mar 14. doi: 10.1245/s10434-026-19198.
PubMed Abstract available

SHAH A, Love JA, Butler M, Butler LN, et al
Integrating Generative AI into Nomograms for Breast Cancer Nodal Risk Predictions.
Ann Surg Oncol. 2026 Mar 13. doi: 10.1245/s10434-026-19482.
PubMed Abstract available

KUEMMEL S, Fasching PA, Schmid P, Harbeck N, et al
ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
Ann Surg Oncol. 2026 Mar 12. doi: 10.1245/s10434-026-19310.
PubMed

AYUB S, Liu Y, Postlewait LM, Arciero C, et al
ASO Author Reflections: Where You Live and How Much You Make Matters in Breast Cancer Care.
Ann Surg Oncol. 2026 Mar 12. doi: 10.1245/s10434-026-19436.
PubMed

MASANAM MK, Kantor O
Reply to: "Breast-Conserving Surgery After Neoadjuvant Therapy in Multiple Ipsilateral Breast Cancer: Points to Consider," by Sanli, Deniz et al.
Ann Surg Oncol. 2026 Mar 11. doi: 10.1245/s10434-026-19358.
PubMed

TEKCAN SANLI DE, Sanli AN
Breast-Conserving Surgery After Neoadjuvant Therapy in Multiple Ipsilateral Breast Cancer: Points to Consider.
Ann Surg Oncol. 2026 Mar 11. doi: 10.1245/s10434-026-19357.
PubMed

RYU HH, Lee YJ, Yoo TK, Kim J, et al
ASO Visual Abstract: Clinical Utility of Oncotype DX Testing in Synchronous Bilateral and Unilateral Multifocal Breast Cancer.
Ann Surg Oncol. 2026 Mar 10. doi: 10.1245/s10434-026-19418.
PubMed

LEVINE A, Terrian L, Bishay D, Lawrence K, et al
ASO Visual Abstract: Reassessing the Role of Regular Physical Examination in Post-treatment Breast Cancer Surveillance.
Ann Surg Oncol. 2026 Mar 9. doi: 10.1245/s10434-026-19391.
PubMed

JIANG X, Huang Z, Wang X, Long J, et al
ASO Visual Abstract: Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer-Development and Validation of a Clinical-Inflammatory Nomogram.
Ann Surg Oncol. 2026 Mar 9. doi: 10.1245/s10434-026-19427.
PubMed

QU FL, Cheng JY, Li JJ, Shao ZM, et al
ASO Author Reflections: Visions in Axilla Management with Clinical Advances in LymphPET for Breast Cancer.
Ann Surg Oncol. 2026 Mar 7. doi: 10.1245/s10434-026-19472.
PubMed

AYUB S, Marra A, Liu Y, Postlewait LM, et al
ASO Visual Abstract: Rurality and Income on Breast Cancer Outcomes: An Analysis of the SEER Database.
Ann Surg Oncol. 2026 Mar 6. doi: 10.1245/s10434-026-19423.
PubMed

JUNG JJ, Kim HK, Kang E, Park EK, et al
Enhancing Early Detection of Contralateral Breast Cancer in Breast Cancer Survivors Using AI-Assisted Mammography.
Ann Surg Oncol. 2026 Mar 6. doi: 10.1245/s10434-026-19348.
PubMed Abstract available

KLIMBERG VS
ASO Author Reflections: Intracavitary Radiofrequency Ablation as a Means to Deescalate Radiation in Patients with Breast Cancer.
Ann Surg Oncol. 2026 Mar 4. doi: 10.1245/s10434-026-19437.
PubMed

YEE GN, Hwang S, Wilke LG, Freedman LM, et al
ASO Visual Abstract: Commission on Cancer Quality Measure for Omission of Sentinel Lymph Node Biopsy (SNB) in Women Aged 70 Years or Older with Hormone Receptor-Positive (HR(+)) Invasive Breast Cancer (IBC) Undergoing Breast-Conserving Surgery (BCS):
Ann Surg Oncol. 2026 Mar 3. doi: 10.1245/s10434-026-19390.
PubMed

KO G, Li Q, Liu N, Amir E, et al
ASO Visual Abstract: Breast Cancer Surgery Wait Times and COVID-19-A Canadian Population-Based Analysis.
Ann Surg Oncol. 2026 Mar 2. doi: 10.1245/s10434-026-19185.
PubMed

SHERN TP, Holt LR, Chamberlain V, Gadd MA, et al
Sentinel Lymph Node Biopsy for Prophylactic Mastectomy: Necessary Precaution or Unnecessary Procedure?
Ann Surg Oncol. 2026;33:2316-2323.
PubMed Abstract available

WEISS A, Jin Q, Tayob N, Wrabel E, et al
Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial.
Ann Surg Oncol. 2026;33:2275-2283.
PubMed Abstract available

WEISS A, Revette A, Nava-Coulter B, Mittendorf EA, et al
Surgeon Perspectives on Axillary Management Following Neoadjuvant Endocrine Therapy: Results from a Qualitative Substudy of the PELOPS Trial.
Ann Surg Oncol. 2026;33:2267-2274.
PubMed Abstract available

HARRIS N, Aiello P, Detz D, Hanssen D, et al
Postoperative Impact of Closed Incision Negative Pressure Therapy Following Oncoplastic Breast Surgery.
Ann Surg Oncol. 2026;33:2013-2018.
PubMed Abstract available

KIM CW, Yoo TK, Kim J, Chung IY, et al
Postoperative Outcomes of Single-Port Robot-Assisted Versus Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction.
Ann Surg Oncol. 2026;33:2246-2254.
PubMed Abstract available

SHAMMAS RL, Wang J, Boe LA, Levy J, et al
Radiation and Reconstructive Failure: Long-Term Outcomes in Two-Stage Flap Versus Implant Breast Reconstruction.
Ann Surg Oncol. 2026;33:1981-1989.
PubMed Abstract available

February 2026

SCHRANK Z, Landrum K, Agala CB, Gallagher K, et al
ASO Visual Abstract: Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.
Ann Surg Oncol. 2026 Feb 28. doi: 10.1245/s10434-026-19334.
PubMed

CHEN C, Ru L
ASO Visual Abstract: Prognostic Associations between Adjuvant Chemotherapy and Survival in T1b-T2N0M0 Medullary Breast Cancer: A Population-Based Study of 2343 Patients.
Ann Surg Oncol. 2026 Feb 28. doi: 10.1245/s10434-026-19271.
PubMed

JIANG X, Huang Z, Cao Y, Ding J, et al
ASO Author Reflections: Toward Personalized Neoadjuvant Therapy in HER2-Positive Breast Cancer-A Clinically Actionable Predictive Model.
Ann Surg Oncol. 2026 Feb 27. doi: 10.1245/s10434-026-19295.
PubMed

SIDHU AS, Chopra AA, Bisch EJ, Chopra A, et al
Psychosocial Morbidity in Patients with Breast Cancer Related Lymphedema: An Evaluation of Mental Health Diagnoses in Breast Cancer Survivors.
Ann Surg Oncol. 2026 Feb 25. doi: 10.1245/s10434-026-19345.
PubMed

KUEMMEL S, Fasching PA, Schmid P, Harbeck N, et al
Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
Ann Surg Oncol. 2026 Feb 25. doi: 10.1245/s10434-026-19121.
PubMed Abstract available

PAN Y, Zhu L
ASO Author Reflections: Large Language Models in Breast Cancer Decision-Making: Lessons from the St. Gallen International Breast Cancer Consensus.
Ann Surg Oncol. 2026 Feb 24. doi: 10.1245/s10434-026-19330.
PubMed

JACINTO AI, Keegan THM, Li Q, Maguire FB, et al
ASO Visual Abstract: Differences in Treatment and Survival for Secondary Triple Negative Breast Cancer in Premenopausal Women.
Ann Surg Oncol. 2026 Feb 24. doi: 10.1245/s10434-026-19126.
PubMed

PAN Y, Duan C, Du J, Zhang J, et al
ASO Visual Abstract: St. Gallen International Breast Cancer Consensus-Based Clinical Decision Validation: Concordance Assessment Between Deep Large Language Model Outputs and Global Expert Panel Recommendations.
Ann Surg Oncol. 2026 Feb 24. doi: 10.1245/s10434-026-19319.
PubMed

DIMAANO K, Castillo O Jr, Moazzez A, Ozao-Choy J, et al
Examining the Representation of Minority Race and Ethnicity Groups in Breast Cancer Clinical Trials in the USA Published 2012-2022.
Ann Surg Oncol. 2026 Feb 23. doi: 10.1245/s10434-026-19214.
PubMed Abstract available

HANNOUN-LEVI JM
ASO Author Reflections: Breast Cancer Local Recurrence: True Recurrence or New Primary?
Ann Surg Oncol. 2026 Feb 22. doi: 10.1245/s10434-026-19297.
PubMed

KASSI A, Rodriguez L, Wu R, Ishikawa T, et al
ASO Author Reflections: PARP7 Association to Estrogen and Immunity in Clinical Breast Cancer.
Ann Surg Oncol. 2026 Feb 21. doi: 10.1245/s10434-026-19296.
PubMed

YEE GN, Hwang S, Wilke LG, Freedman LM, et al
Commission on Cancer Quality Measure for Omission of Sentinel Lymph Node Biopsy (SNB) in Women Age 70 or Older with Hormone Receptor-Positive (HR+) Invasive Breast Cancer (IBC) Undergoing Breast-Conserving Surgery (BCS): Review of Historical Performan
Ann Surg Oncol. 2026 Feb 21. doi: 10.1245/s10434-026-19222.
PubMed Abstract available

AYUB S, Marra A, Liu Y, Postlewait LM, et al
Rurality and Income on Breast Cancer Outcomes: An Analysis of the SEER Database.
Ann Surg Oncol. 2026 Feb 19. doi: 10.1245/s10434-026-19254.
PubMed Abstract available

RODRIGUEZ L, Wu R, Kassi A, Ishikawa T, et al
High PARP7 Expression is Associated with Higher Estrogen Response and Immune Suppression but Less Cell Proliferation and Better Survival in Breast Cancer.
Ann Surg Oncol. 2026 Feb 19. doi: 10.1245/s10434-026-19133.
PubMed Abstract available

KINOSHITA T, Takayama S, Fujisawa T, Watanabe K, et al
Radiofrequency Ablation for Early Stage Breast Cancer as a Potential Alternative to Partial Mastectomy: 5-Year Results from the Multiple-Center, Single-Arm, Phase 3 RAFAELO Study (NCCH1409).
Ann Surg Oncol. 2026 Feb 18. doi: 10.1245/s10434-026-19220.
PubMed Abstract available

PUJOL N, Gal J, Gautier M, Rizzi Y, et al
Second Ipsilateral Breast Cancer Event: True Recurrence, New Primary, or True Recurrence Like? : Breast Cancer Local Recurrence.
Ann Surg Oncol. 2026 Feb 18. doi: 10.1245/s10434-026-19131.
PubMed Abstract available

SCHRANK Z, Selfridge JM
ASO Author Reflections: Do Older Triple-Negative Breast Cancer Patients Respond Differently to Neoadjuvant Chemoimmunotherapy?
Ann Surg Oncol. 2026 Feb 18. doi: 10.1245/s10434-026-19299.
PubMed

ABDULLA HA, McGarry J, Kaczorowska R, Grealish A, et al
ASO Visual Abstract: Oncological Outcomes of Sentinel Lymph Node Biopsy Versus Targeted Axillary Dissection in Node-Positive Breast Cancer Patients After Neoadjuvant Chemotherapy: A Systematic Review and Meta-analysis.
Ann Surg Oncol. 2026 Feb 18. doi: 10.1245/s10434-026-19273.
PubMed

JAYASWAL RP
Letter Comments on: Differences in Breast Cancer Care Between Rural Women Undergoing Treatment at a Referral Center and Those Treated Locally.
Ann Surg Oncol. 2026 Feb 17. doi: 10.1245/s10434-026-19258.
PubMed

RYU HH, Lee YJ, Yoo TK, Kim J, et al
Clinical Utility of Oncotype DX Testing in Synchronous Bilateral and Unilateral Multifocal Breast Cancer.
Ann Surg Oncol. 2026 Feb 16. doi: 10.1245/s10434-026-19243.
PubMed Abstract available

JIANG X, Huang Z, Wang X, Long J, et al
Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer: Development and Validation of a Clinical-Inflammatory Nomogram.
Ann Surg Oncol. 2026 Feb 14. doi: 10.1245/s10434-026-19178.
PubMed Abstract available

LEVINE A, Terrian L, Bishay D, Lawrence K, et al
Reassessing the Role of Regular Physical Examination in Post-treatment Breast Cancer Surveillance.
Ann Surg Oncol. 2026 Feb 12. doi: 10.1245/s10434-026-19227.
PubMed Abstract available

KO G, Cil TD
ASO Author Reflections: Patterns of Breast Cancer Management and Surgical Wait Times During the COVID-19 Pandemic.
Ann Surg Oncol. 2026 Feb 12. doi: 10.1245/s10434-026-19206.
PubMed

PAN Y, Duan C, Du J, Zhang J, et al
St. Gallen International Breast Cancer Consensus-Based Clinical Decision Validation: Concordance Assessment Between Deep Large Language Model Outputs and Global Expert Panel Recommendations.
Ann Surg Oncol. 2026 Feb 10. doi: 10.1245/s10434-026-19176.
PubMed Abstract available

WANG J, Chen J, Amburn T, Wagner BD, et al
Axillary Lymph Node Dissection Through a Separate Incision Does Not Increase Rates of Breast Cancer-Related Lymphedema.
Ann Surg Oncol. 2026 Feb 10. doi: 10.1245/s10434-026-19215.
PubMed Abstract available

MASANAM MK, Bellon JR, Leone JP, Mittendorf EA, et al
ASO Visual Abstract: Breast-Conserving Therapy for Multiple Ipsilateral Breast Cancer After Neoadjuvant Systemic Therapy.
Ann Surg Oncol. 2026 Feb 9. doi: 10.1245/s10434-026-19163.
PubMed

HOLMES DR
ASO Author Reflections: Breast Cancer Cryoablation-A Targeted, Patient-Centered Approach Surgeons Should Embrace.
Ann Surg Oncol. 2026 Feb 9. doi: 10.1245/s10434-026-19144.
PubMed

ELAM M, Hillas J, Moyal-Smith R, Padamsee TJ, et al
ASO Visual Abstract: Bridging Operative Standards to Clinical Practice: A Case Comparison of Synoptic Operative Report Implementation in Breast Cancer Surgery.
Ann Surg Oncol. 2026 Feb 7. doi: 10.1245/s10434-026-19190.
PubMed

FENTENER VAN VLISSINGEN EMALC, Postma EL, Scholten AN, van der Leij F, et al
ASO Visual Abstract: The Clinical Impact of the Surgical Removal of the Internal Mammary Chain Sentinel Node in Breast Cancer Patients: Do We Need to De-Escalate Our Former Strategy? Reevaluating the Role of Internal Mammary Sentinel Node Removal in B
Ann Surg Oncol. 2026 Feb 5. doi: 10.1245/s10434-026-19159.
PubMed

RAYMAKERS AM, King TA, Mittendorf EA, Dey T, et al
ASO Visual Abstract: Impact of Breast-Cancer-Related Lymphedema on Cancer Care Costs: Longitudinal and Age-Based Analyses.
Ann Surg Oncol. 2026 Feb 3. doi: 10.1245/s10434-026-19141.
PubMed

TSUCHIDA J, Wu R, Nagahashi M, Ebos JML, et al
ASO Visual Abstract: TRIM37 Expression is Associated with Immune Suppression, Poor Response to Neoadjuvant Chemotherapy, and Worse Survival in ER-Positive/HER2-Negative Breast Cancer.
Ann Surg Oncol. 2026 Feb 2. doi: 10.1245/s10434-026-19108.
PubMed

LUDWIG KK, Kong A, Grossi S, Joseph KA, et al
Implementation of Quality Improvement Projects: A Practical Guide From the American Society of Breast Surgeons Patient Safety and Quality Committee.
Ann Surg Oncol. 2026;33:1221-1231.
PubMed Abstract available

STURZ-ELLIS JL, Vetter CD, Day CN, Boughey JC, et al
A Systematic Review of Occult Malignancy and Sentinel Lymph Node Metastasis at the Time of Contralateral Prophylactic Mastectomy.
Ann Surg Oncol. 2026;33:1162-1170.
PubMed Abstract available

FISH EM, Whittall I, Lyons W, Bleicher RJ, et al
Axillary Management Trends and Survival in Men Undergoing Mastectomy with Positive Sentinel Nodes.
Ann Surg Oncol. 2026;33:1150-1161.
PubMed Abstract available

January 2026

ELAM M, Hillas J, Moyal-Smith R, Padamsee TJ, et al
Bridging Operative Standards to Clinical Practice: A Case Comparison of Synoptic Operative Report Implementation in Breast Cancer Surgery.
Ann Surg Oncol. 2026 Jan 27. doi: 10.1245/s10434-025-19042.
PubMed Abstract available

KO G, Li Q, Liu N, Amir E, et al
Breast Cancer Surgery Wait Times and COVID-19: A Canadian Population-Based Analysis.
Ann Surg Oncol. 2026 Jan 25. doi: 10.1245/s10434-025-19029.
PubMed Abstract available

BEERTHUIZEN AWJ, Snellen TIM, Bartels SA, Kuijer A, et al
ASO Visual Abstract: The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial.
Ann Surg Oncol. 2026 Jan 24. doi: 10.1245/s10434-025-19063.
PubMed

BARMETTLER G, Leonard S, Giannakou A, Park KU, et al
ASO Visual Abstract: Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities.
Ann Surg Oncol. 2026 Jan 22. doi: 10.1245/s10434-025-19077.
PubMed

DAY CN, Habermann EB, Boughey JC
Evolution of Breast Cancer Treatment 2010-2023.
Ann Surg Oncol. 2026 Jan 20. doi: 10.1245/s10434-025-19065.
PubMed Abstract available

GALLAGHER K, Feldman S, Barone J, Mammen J, et al
Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer.
Ann Surg Oncol. 2026 Jan 18. doi: 10.1245/s10434-025-19008.
PubMed Abstract available

SHEN Y, Gadiraju GK, Gao R, Raymakers AM, et al
ASO Visual Abstract: Breast Reconstruction for Inflammatory Breast Cancer: Improving Patient-Reported Outcomes in a High-Risk Population.
Ann Surg Oncol. 2026 Jan 17. doi: 10.1245/s10434-025-18841.
PubMed

ABDULLA HA, McGarry J, Kaczorowska R, Grealish A, et al
Oncologic Outcomes of Sentinel Lymph Node Biopsy Versus Targeted Axillary Dissection for Node-Positive Breast Cancer Patients After Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis.
Ann Surg Oncol. 2026 Jan 16. doi: 10.1245/s10434-025-19070.
PubMed Abstract available

HOLMES DR, Manoian S, Rahman RL, Ward RC, et al
Cryoablation: A Minimally Invasive Alternative for Early-Stage Breast Cancer: 6-Year Outcomes of the FROST Clinical Trial.
Ann Surg Oncol. 2026 Jan 15. doi: 10.1245/s10434-025-18991.
PubMed Abstract available

DOUGLAS SR, Thomas SM, Chiba A, Botty van den Bruele A, et al
ASO Author Reflections: Moving Toward Evidence-Based Guidelines for Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.
Ann Surg Oncol. 2026 Jan 14. doi: 10.1245/s10434-025-18331.
PubMed

CHEN C, Ru L
Prognostic Associations Between Adjuvant Chemotherapy and Survival in T1b-T2N0M0 Medullary Breast Cancer: A Population-Based Study of 2343 Patients.
Ann Surg Oncol. 2026 Jan 14. doi: 10.1245/s10434-025-19054.
PubMed Abstract available

DZUBNAR JM, Habel LA, Jiang SF, Karlea A, et al
Multigene Germline Testing in Patients with DCIS vs Invasive Breast Cancer in a Large, Integrated Health Care System.
Ann Surg Oncol. 2026 Jan 13. doi: 10.1245/s10434-025-19053.
PubMed Abstract available

ROSS VMS, Addie M, Pickard MR, Josey V, et al
ASO Visual Abstract: Axillary Management in Patients with Breast Cancer with Positive Lymph Nodes Following Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2026 Jan 12. doi: 10.1245/s10434-025-19036.
PubMed

GNANGNON FHR, Parente A, Allayambaye TE, Sacca HR, et al
Epidemiology and Clinical Features of Breast Cancer in Cotonou (2014-2019): Insights from a Population-Based Registry Study.
Ann Surg Oncol. 2026 Jan 11. doi: 10.1245/s10434-025-18976.
PubMed Abstract available

JACINTO AI, Keegan THM, Li Q, Maguire FB, et al
Differences in Treatment and Survival for Secondary Triple Negative Breast Cancer in Premenopausal Women.
Ann Surg Oncol. 2026 Jan 9. doi: 10.1245/s10434-025-18892.
PubMed Abstract available

JACINTO AI, Sauder C
ASO Author Reflections: Treating Secondary Triple Negative Breast Cancer in Younger Women.
Ann Surg Oncol. 2026 Jan 7. doi: 10.1245/s10434-025-19016.
PubMed

WANG Z, Gu L, Yang M, Zhou Y, et al
NUP62 Elevates USP10 Expression and Promotes Tamoxifen Resistance of Breast Cancer by Deubiquitinating ERalpha.
Ann Surg Oncol. 2026 Jan 7. doi: 10.1245/s10434-025-18995.
PubMed Abstract available

VAN GEMERT D, Beelen LM, Mos J, van Egdom L, et al
ASO Author Reflections: Beyond Treatment Intensity: Understanding Individual Susceptibility in Breast Cancer-Related Lymphedema (BCRL).
Ann Surg Oncol. 2026 Jan 7. doi: 10.1245/s10434-025-18851.
PubMed

BEERTHUIZEN AWJ, van Duijnhoven FH
ASO Author Reflections: The Added Value of Axillary Ultrasound in Early Breast Cancer: Insights from the AMAROS Trial.
Ann Surg Oncol. 2026 Jan 6. doi: 10.1245/s10434-025-18998.
PubMed

VAN VLISSINGEN EMALCF, Postma EL, Scholten AN, van der Leij F, et al
The Clinical Impact of the Surgical Removal of the Internal Mammary Chain Sentinel Node in Breast Cancer Patients: Do We Need to De-Escalate our Former Strategy?
Ann Surg Oncol. 2026 Jan 5. doi: 10.1245/s10434-025-18930.
PubMed Abstract available

PARMAR P, Lin J, Bhimani F, Jao L, et al
ASO Visual Abstract: Zip-Code-Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation.
Ann Surg Oncol. 2026 Jan 5. doi: 10.1245/s10434-025-18860.
PubMed

MASANAM MK, Bellon JR, Leone JP, Mittendorf EA, et al
Breast-Conserving Therapy for Multiple Ipsilateral Breast Cancer After Neoadjuvant Systemic Therapy.
Ann Surg Oncol. 2026 Jan 3. doi: 10.1245/s10434-025-18939.
PubMed Abstract available

VAN VLISSINGEN EMALCF, van der Ploeg IMC
ASO Author Reflections: De-Escalating Internal Mammary Sentinel Node Surgery in Breast Cancer.
Ann Surg Oncol. 2026 Jan 3. doi: 10.1245/s10434-025-18973.
PubMed

WANG T, Neish D, Thomas S, Botty van den Bruele A, et al
ASO Visual Abstract: Radiation Deescalation in Older Women with Early Stage ER+/HER2- Invasive Breast Cancer.
Ann Surg Oncol. 2026 Jan 3. doi: 10.1245/s10434-025-19009.
PubMed

MELANSON A, Mashal S, Apostolova C, Ferroum A, et al
Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age.
Ann Surg Oncol. 2026;33:108-117.
PubMed Abstract available

WANG J, Shammas RL, Graziano FD, Boe LA, et al
One or Two Drains? A Propensity Score-Matched Analysis of Postoperative Complications After Tissue Expander Placement.
Ann Surg Oncol. 2026;33:668-675.
PubMed Abstract available

BROWN S, Shen Y, Klimitz FJ, Nair M, et al
Immediate Lymphatic Reconstruction (ILR) for the Prevention of Lymphedema: A Meta-analysis of Prospective Clinical Trials.
Ann Surg Oncol. 2026;33:60-76.
PubMed Abstract available

OZAWA N, Takeyama E, Sakai H, Katayama A, et al
Molecular and Biological Features of Invasive Lobular Carcinoma: Toward New Treatment Strategies.
Ann Surg Oncol. 2026;33:146-158.
PubMed Abstract available

NAASEH A, Bewley AF, Nickel KB, Myckatyn TM, et al
Impact of Sociodemographic and Clinical Factors on Postoperative Outcomes Following Immediate Postmastectomy Autologous Breast Reconstruction.
Ann Surg Oncol. 2026;33:658-667.
PubMed Abstract available

CHANDLER JM, Kim M, Sevilimedu V, Le TV, et al
Trends in Patient-Reported Outcomes After Breast-Conserving Surgery and Partial-Breast Versus Whole-Breast Irradiation.
Ann Surg Oncol. 2026;33:50-59.
PubMed Abstract available

ZAVERI S, Sun SX, Bevers TB, Albarracin CT, et al
Implications of the COMET Trial for the Management of Atypical Ductal Hyperplasia.
Ann Surg Oncol. 2026;33:43-49.
PubMed Abstract available

December 2025

VETTER C, Day CN, Habermann EB, Boughey JC, et al
Differences in Breast Cancer Care Between Rural Women Undergoing Treatment at a Referral Center and Those Treated Locally.
Ann Surg Oncol. 2025 Dec 29. doi: 10.1245/s10434-025-18812.
PubMed Abstract available

BARMETTLER G, Kantor O
ASO Author Reflections: Identifying Differences in Treatment Patterns in Sexual and Gender Minorities with Breast Cancer.
Ann Surg Oncol. 2025 Dec 27. doi: 10.1245/s10434-025-18964.
PubMed

VETTER C, Day CN, Habermann EB, Boughey JC, et al
ASO Visual Abstract: Differences in Breast Cancer Care Between Rural Women Undergoing Treatment at a Referral Center Compared with Those Treated Locally.
Ann Surg Oncol. 2025 Dec 24. doi: 10.1245/s10434-025-18920.
PubMed

VAN GEMERT D, Beelen LM, Mos J, van Egdom L, et al
ASO Visual Abstract: Breast Cancer-Related Lymphedema (BCRL): Comprehensive Characterization of Patients Seeking Microsurgical Treatment.
Ann Surg Oncol. 2025 Dec 17. doi: 10.1245/s10434-025-18861.
PubMed

LEE JA, Lee HS, Jeon S, Kim D, et al
ASO Visual Abstract: Risk Factors and Incidence of Reoperation in Direct-to-Implant Breast Reconstruction Surgery Among Patients with Breast Cancer.
Ann Surg Oncol. 2025 Dec 17. doi: 10.1245/s10434-025-18845.
PubMed

ROSS VMS, Addie M, Roy Pickard M, Josey V, et al
ASO Author Reflections: Neoadjuvant Chemotherapy and Prediction of Residual Axillary Disease in Breast Cancer Patients.
Ann Surg Oncol. 2025 Dec 16. doi: 10.1245/s10434-025-18905.
PubMed

RAYMAKERS AM, King TA, Mittendorf EA, Dey T, et al
Impact of Breast Cancer-Related Lymphedema on Cancer Care Costs: Longitudinal and Age-Based Analyses.
Ann Surg Oncol. 2025 Dec 16. doi: 10.1245/s10434-025-18875.
PubMed Abstract available

MA D, Cao H, Wu J, Shang T, et al
ASO Visual Abstract: Analysis of the Current Status of de Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.
Ann Surg Oncol. 2025 Dec 16. doi: 10.1245/s10434-025-18868.
PubMed

BEERTHUIZEN AWJ, Snellen TIM, Bartels SA, Kuijer A, et al
The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial.
Ann Surg Oncol. 2025 Dec 14. doi: 10.1245/s10434-025-18833.
PubMed Abstract available

HANS M, Tamaskar AS, Recko A, Bychkovsky BL, et al
ASO Visual Abstract: Evaluating the Implementation and Maintenance of a Breast Cancer Risk Assessment and Prevention Program.
Ann Surg Oncol. 2025 Dec 13. doi: 10.1245/s10434-025-18844.
PubMed

BARMETTLER G, Leonard S, Giannakou A, Park KU, et al
Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities.
Ann Surg Oncol. 2025 Dec 11. doi: 10.1245/s10434-025-18853.
PubMed Abstract available

COBB AN, Dong X, Makope A, Cohen L, et al
ASO Visual Abstract: Contemporary Nodal Management and Overall Survival in Older Patients with HR-/HER2+ Breast Cancer.
Ann Surg Oncol. 2025 Dec 8. doi: 10.1245/s10434-025-18836.
PubMed

LEE K, Pallesi A, Valdez BJ, Hanes DA, et al
Factors Associated With Residual Disease on Re-Excision Specimens After Breast-Conserving Surgery for Breast Cancer.
Ann Surg Oncol. 2025 Dec 6. doi: 10.1245/s10434-025-18813.
PubMed Abstract available

DOUGLAS SR, Thomas SM, Chiba A, DiNome ML, et al
ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
Ann Surg Oncol. 2025 Dec 4. doi: 10.1245/s10434-025-18393.
PubMed

TSUCHIDA J, Wu R, Nagahashi M, Ebos JML, et al
ASO Author Reflections: DNA Repair and Tumor Immunity in Breast Cancer: A Context-Dependent Role for TRIM37.
Ann Surg Oncol. 2025 Dec 2. doi: 10.1245/s10434-025-18852.
PubMed

ULANER GA, Khan S, Savalia NB, Lopez J, et al
The Van Nuys DCIS Prognostic Index -->The Silverstein DCIS Prognostic Index.
Ann Surg Oncol. 2025;32:9475-9477.
PubMed Abstract available

JENSEN S, Tvedskov TF, Bechmann T, Tramm T, et al
Additional Axillary Disease After Neoadjuvant Chemotherapy for Patients with Clinically Node-Negative but Sentinel Node-Positive Disease.
Ann Surg Oncol. 2025;32:9807-9816.
PubMed Abstract available

GWARK S, Hwang YH, Paek SH, Lee YW, et al
Early Postoperative Outcomes of Tumescent-Free Single-Port Robot-Assisted Nipple-Sparing Mastectomy Compared with Tumescent-Using Technique: A Substudy of Retrospective Multicenter Study (SPROUT, KoREa-BSG 14).
Ann Surg Oncol. 2025;32:9787-9797.
PubMed Abstract available

ROSENBERG SM, Rushing C, Schreiber KL, Crowell KA, et al
Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study.
Ann Surg Oncol. 2025;32:9776-9786.
PubMed Abstract available

DE OLIVEIRA-JUNIOR I, Gonzaga MI, Amirati CC, Vilela NM, et al
Primary Breast Implant-Associated Squamous Cell Carcinoma: A Proposal for a Better Surgical Approach and Clinical Staging System Based on Tumour Characteristics.
Ann Surg Oncol. 2025;32:9857-9867.
PubMed Abstract available

PARMAR P, Lin J, Bhimani F, Jao L, et al
Zip-Code Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation.
Ann Surg Oncol. 2025 Dec 1. doi: 10.1245/s10434-025-18693.
PubMed Abstract available

November 2025

ROSS VMS, Addie M, Roy Pickard M, Josey V, et al
Axillary Management in Breast Cancer Patients with Positive Lymph Nodes Following Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2025 Nov 26. doi: 10.1245/s10434-025-18783.
PubMed Abstract available

COBB AN, Dong X, Makope A, Cohen L, et al
Correction: Contemporary Nodal Management and Overall Survival of Older Patients with HR-/HER2+ Breast Cancer.
Ann Surg Oncol. 2025 Nov 25. doi: 10.1245/s10434-025-18811.
PubMed

GHOSH M, Hoysal DR, Deshpande A, Badwe RA, et al
Letter to the Editor "Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial".
Ann Surg Oncol. 2025 Nov 25. doi: 10.1245/s10434-025-18788.
PubMed

SHEN Y, Gadiraju GK, Gao R, Nakhlis Md F, et al
ASO Author Reflections: Beyond Survival: Restoring Quality of Life in Inflammatory Breast Cancer.
Ann Surg Oncol. 2025 Nov 24. doi: 10.1245/s10434-025-18700.
PubMed

TEKCAN SANLI DE, Sanli AN
Evaluating Survival and Treatment Patterns Using the National Cancer Database in HER2-Positive Breast Cancer.
Ann Surg Oncol. 2025 Nov 24. doi: 10.1245/s10434-025-18796.
PubMed

WANG T, Neish D, Thomas S, Botty van den Bruele A, et al
Radiation De-Escalation in Older Women with Early-Stage ER+/HER2- Invasive Breast Cancer.
Ann Surg Oncol. 2025 Nov 23. doi: 10.1245/s10434-025-18746.
PubMed Abstract available

WAGNER BD, Rubin J, Lin IH, Raina J, et al
ASO Visual Abstract: Clinical Features, Microbial Epidemiology, and Recurrence Risk of Cellulitis in Breast Cancer-Related Lymphedema.
Ann Surg Oncol. 2025 Nov 23. doi: 10.1245/s10434-025-18789.
PubMed

RANGEL M, Paul S, Gupta D, McPeek C, et al
ASO Visual Abstract: Evaluating the Gail Model: Racial Disparities in Breast Cancer Risk Assessment.
Ann Surg Oncol. 2025 Nov 23. doi: 10.1245/s10434-025-18753.
PubMed

COBB AN, Cortina CS
Reply to: Letter to the Editor of Annals of Surgical Oncology Concerning "Evaluating Survival and Treatment Patterns Using the National Cancer Database in HER2-Positive Breast Cancer," by Sanli, Deniz et al.
Ann Surg Oncol. 2025 Nov 22. doi: 10.1245/s10434-025-18797.
PubMed

TSUCHIDA J, Wu R, Nagahashi M, Ebos JML, et al
TRIM37 Expression is Associated with Immune Suppression Poor Response to Neoadjuvant Chemotherapy and Worse Survival in ER-Positive/HER2-Negative Breast Cancer.
Ann Surg Oncol. 2025 Nov 21. doi: 10.1245/s10434-025-18764.
PubMed Abstract available

MARTELLI G, Barretta F, Muzi C, Listorti C, et al
Sentinel Node Biopsy Alone Versus Sentinel Node Biopsy Plus Axillary Dissection in cT2 cN0/1 Breast Cancer After Neoadjuvant Chemotherapy: 15-Year Results of a Prospective Interventional Study.
Ann Surg Oncol. 2025 Nov 18. doi: 10.1245/s10434-025-18673.
PubMed Abstract available

VAN GEMERT D, Beelen LM, Mos J, van Egdom L, et al
Breast Cancer-Related Lymphedema (BCRL): Comprehensive Characterization of Patients Seeking Microsurgical Treatment.
Ann Surg Oncol. 2025 Nov 18. doi: 10.1245/s10434-025-18694.
PubMed Abstract available

MARTELLI G
ASO Author Reflections: No Further Axillary Treatment is Safe if the Sentinel Nodes are Negative After Neoadjuvant Chemotherapy in cT2 cN1 Breast Cancer.
Ann Surg Oncol. 2025 Nov 15. doi: 10.1245/s10434-025-18775.
PubMed

KOBZEVA-HERZOG AJ, Palaniappan S, Jiangliu Y, Kraus E, et al
ASO Visual Abstract: A Multidisciplinary Breast Cancer Clinic Improves Time to Treatment at an Urban, Safety Net Hospital.
Ann Surg Oncol. 2025 Nov 15. doi: 10.1245/s10434-025-18677.
PubMed

YOO JW, Byeon J, Park WK, Kim J, et al
Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer.
Ann Surg Oncol. 2025 Nov 14. doi: 10.1245/s10434-025-18713.
PubMed Abstract available

MA D, Cao H, Wu J, Shang T, et al
ASO Author Reflections: Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.
Ann Surg Oncol. 2025 Nov 6. doi: 10.1245/s10434-025-18643.
PubMed

SHEN Y, Gadiraju GK, Gao R, Raymakers AM, et al
Breast Reconstruction for Inflammatory Breast Cancer: Improving Patient-Reported Outcomes in a High-Risk Population.
Ann Surg Oncol. 2025 Nov 6. doi: 10.1245/s10434-025-18640.
PubMed Abstract available

LEE JA, Lee HS, Jeon S, Kim D, et al
Risk Factors and Incidence of Reoperation in Direct-to-Implant Breast Reconstruction Surgery Among Patients with Breast Cancer.
Ann Surg Oncol. 2025 Nov 3. doi: 10.1245/s10434-025-18662.
PubMed Abstract available

HANS M, Tamaskar AS, Recko A, Bychkovsky BL, et al
Evaluating the Implementation and Maintenance of a Breast Cancer Risk-Assessment and Prevention Program.
Ann Surg Oncol. 2025 Nov 1. doi: 10.1245/s10434-025-18656.
PubMed Abstract available

BRABENDER D, Siegel E, Culver JO, Comeaux JG, et al
Identification of Patients at Elevated Cancer Risk through a Community-Based Genetic Testing Program.
Ann Surg Oncol. 2025;32:9041-9049.
PubMed Abstract available

DE CARDOSO DIAS I, Mora HF, Peleteiro B, Fougo JL, et al
Breast-Conserving Oncoplastic Surgery Stratification: Morbidity Retrospective Analysis and its Association with Procedure Complexity Level.
Ann Surg Oncol. 2025;32:8769-8779.
PubMed Abstract available

VERTIDO A, McKenzie T, Othieno A, Quirarte A, et al
Accuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular Carcinoma.
Ann Surg Oncol. 2025;32:8710-8719.
PubMed Abstract available

October 2025

TORTORELLO GN, Shafique N, De Jesus EM, Gimotty P, et al
Sentinel Lymph Node Biopsy in Low-Risk Breast Cancer in Patients >/= 70 Years: How Wisely are We Choosing?
Ann Surg Oncol. 2025 Oct 30. doi: 10.1245/s10434-025-18534.
PubMed Abstract available

HAMID SA, Moses J, Lynch OF, Washington R, et al
ASO Visual Abstract: Financial Outlook thRough CAncer STorytelling (FOReCAST): Development of a Novel Video-Based Storytelling Intervention to Mitigate Financial Hardship Among Young Women with Breast Cancer.
Ann Surg Oncol. 2025 Oct 27. doi: 10.1245/s10434-025-18585.
PubMed

COX CE, Schumacher J, Lillie M, Carino J, et al
Simultaneous Omission of Sentinel Lymph Node Biopsy and Radiation in Older Women with Early ER+ Breast Cancer.
Ann Surg Oncol. 2025 Oct 27. doi: 10.1245/s10434-025-18631.
PubMed Abstract available

RANGEL M, Paul S, Gupta D, McPeek C, et al
Evaluating the Gail Model: Racial Disparities in Breast Cancer Risk Assessment.
Ann Surg Oncol. 2025 Oct 25. doi: 10.1245/s10434-025-18593.
PubMed Abstract available

TANG A, Wu PS, Farmah P, Schulz-Costello K, et al
Omission of Axillary Lymph Node Dissection in Patients with pT0-2 ER+/HER2- Breast Cancer with 3-5 Positive Lymph Nodes Undergoing Adjuvant Systemic Therapy and Radiation Does Not Impact Overall Survival: A National Cancer Database Analysis.
Ann Surg Oncol. 2025 Oct 24. doi: 10.1245/s10434-025-18546.
PubMed Abstract available

VETTER CD, Hoskin T, Olson C, Giridhar K, et al
ASO Visual Abstract: Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of Performance for Cancer-Specific Outcomes.
Ann Surg Oncol. 2025 Oct 22. doi: 10.1245/s10434-025-18350.
PubMed

ARIMA J, Chida K, Wu R, Taniguchi K, et al
ASO Visual Abstract: ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in ER-Positive HER2-Negative Breast Cancer.
Ann Surg Oncol. 2025 Oct 22. doi: 10.1245/s10434-025-18480.
PubMed

WAGNER BD, Rubin J, Lin IH, Raina J, et al
Clinical Features, Microbial Epidemiology, and Recurrence Risk of Cellulitis in Breast Cancer-Related Lymphedema.
Ann Surg Oncol. 2025 Oct 19. doi: 10.1245/s10434-025-18598.
PubMed Abstract available

KOBZEVA-HERZOG AJ, Palaniappan S, Jiangliu Y, Kraus E, et al
A Multidisciplinary Breast Cancer Clinic Improves Time to Treatment at an Urban, Safety Net Hospital.
Ann Surg Oncol. 2025 Oct 17. doi: 10.1245/s10434-025-18497.
PubMed Abstract available

DOUGLAS SR, Thomas SM, van den Bruele AB, Wang T, et al
ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic.
Ann Surg Oncol. 2025 Oct 15. doi: 10.1245/s10434-025-18495.
PubMed

HUANG SY, Murray M, Rubio A, Okoro N, et al
ASO Visual Abstract: Impact of Screening Mammography on Breast Cancer Outcomes in Women Aged 80 Years and Over.
Ann Surg Oncol. 2025 Oct 10. doi: 10.1245/s10434-025-18488.
PubMed

MA D, Cao H, Wu J, Shang T, et al
Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the USA: A Multicenter Real-World Study.
Ann Surg Oncol. 2025 Oct 10. doi: 10.1245/s10434-025-18490.
PubMed Abstract available

COBB AN, Cortina CS
ASO Author Reflections: Prognostic and Therapeutic Implications of Nodal Burden in HER2-Positive Breast Cancer.
Ann Surg Oncol. 2025 Oct 10. doi: 10.1245/s10434-025-18525.
PubMed

CHAKRABORTY M, Sherwani Z, Narra LR, Yehia ZA, et al
Reply to: "Preoperative Radiation Boost in Early Stage Breast Cancer: Effect on Re-excision and Complication Rates," by Sanli, Deniz et al.
Ann Surg Oncol. 2025 Oct 8. doi: 10.1245/s10434-025-18489.
PubMed

WAGNER BD, Rubin J, Boe LA, Diwan R, et al
ASO Visual Abstract: Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy.
Ann Surg Oncol. 2025 Oct 8. doi: 10.1245/s10434-025-18509.
PubMed

BIRGIN E, Rahbari NN
Robotic Central Hepatectomy.
Ann Surg Oncol. 2025;32:7252-7253.
PubMed Abstract available

PHANG F, Finkelman B, Gooch J, Olzinski-Kunze A, et al
Real-World Application of Alliance ACOSOG Z11102: How Many Patients Can be Spared Mastectomy?
Ann Surg Oncol. 2025;32:8271-8279.
PubMed Abstract available

CHINN J, Earley M, Dashevsky BZ, Stone K, et al
Comparison of Two Wireless Localization Technologies for Removal of Non-palpable Breast Lesions: SCOUT((R)) Radar Reflector and Pintuition((R)) Magnetic Seed.
Ann Surg Oncol. 2025;32:8280-8285.
PubMed Abstract available

FERRUCCI M, Milardi F, Passeri D, Miglioranza E, et al
The Combination of Chest Wall Perforator Flaps and Surgeon-Performed Breast Ultrasound: An Effective Synergy to Expand the Boundaries of Breast-Conserving Surgery.
Ann Surg Oncol. 2025;32:8538-8551.
PubMed Abstract available

PLICHTA JK, Bleicher RJ, Boughey J, Margenthaler JA, et al
Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants' and Program Directors' Preferences Regarding In-Person Versus Virtual Interviews.
Ann Surg Oncol. 2025;32:8514-8522.
PubMed Abstract available

SANTORO CN, Hoskin TL, Olson CA, Boughey JC, et al
Is the Clipped Node Enough? Successful Retrieval and False Negative Rate of the Clipped Node After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2025;32:8129-8139.
PubMed Abstract available

NAASEH A, Tang SX, Lipsey KL, Politi MC, et al
Feasibility and Efficacy of Decision Aids to Improve Decision-Making for Contralateral Prophylactic Mastectomy: A Systematic Review.
Ann Surg Oncol. 2025;32:8325-8337.
PubMed Abstract available

DICKERSON F, Wiener AA, Breuer C, Schumacher J, et al
Breast Surgeons' Perspectives of Telehealth Visits for Breast Clinic.
Ann Surg Oncol. 2025;32:8463-8471.
PubMed Abstract available

HUYNH V, Glencer A, Yi M, Wingate E, et al
Impact of Pathologic Complete Response on Local-Regional Recurrence and Survival in Patients Undergoing Neoadjuvant Systemic Therapy and Breast-Conserving Surgery.
Ann Surg Oncol. 2025;32:8160-8167.
PubMed Abstract available

MILLARD T, Turkheimer LM, Petroni G, Brighton D, et al
Ninety Days of Preoperative Endocrine Therapy Informs Patient and Physician Preference for Radiation Therapy: Primary Results from the Preoperative Window of Endocrine Therapy to Inform Radiation Therapy Decisions (POWER) Trial.
Ann Surg Oncol. 2025;32:8169-8179.
PubMed Abstract available

MARTIN G, Kensler KH, An A, Gemson E, et al
Closing the Gap: Disparities in Breast Reconstruction After Mastectomy.
Ann Surg Oncol. 2025;32:8313-8322.
PubMed Abstract available

AMBURN T, Farahani S, Sevilimedu V, Brogi E, et al
Nipple Discharge and Pathologic Involvement of the Nipple-Areolar Complex: Reconsidering Guidelines for Nipple-Sparing Mastectomy.
Ann Surg Oncol. 2025;32:8434-8444.
PubMed Abstract available

SLOBIN J, Travers G, Perez J, Collins V, et al
Added Value of Fine-Needle Aspiration (FNA) or Breast Magnetic Resonance Imaging (MRI) as Part of the "Triple Test" to Assess Palpable Abnormalities on a Breast Exam With Negative Imaging Findings.
Ann Surg Oncol. 2025;32:8378-8385.
PubMed Abstract available

CHAN K, Palis BE, Cotler JH, Bleicher RJ, et al
Association of Surgeon Volume with Adherence to American Society of Breast Surgeons Surgical Quality Measures.
Ann Surg Oncol. 2025;32:8144-8155.
PubMed Abstract available

REAGAN AM, Jones VM, Ibrahim-Zada I, Smith SR, et al
Characterizing the General Surgery Experience of Future Breast Surgeons: A Multi-institutional Study from the US ROPE Consortium.
Ann Surg Oncol. 2025;32:8340-8348.
PubMed Abstract available

REASON EH, Aiduk MD, Nash AL, McDuff SGR, et al
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study.
Ann Surg Oncol. 2025;32:8299-8308.
PubMed Abstract available

KAUR M, Dimitroff K, Boughey JC, Esserman LJ, et al
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial.
Ann Surg Oncol. 2025;32:8211-8219.
PubMed Abstract available

BHEEMIREDDY S, Leslie SE, Durden JA, Burnet G, et al
The Use of ChatGPT-4.0 to Simplify Breast Pathology Reports: A Study on Readability and Accuracy.
Ann Surg Oncol. 2025;32:8400-8408.
PubMed Abstract available

SUMMERSIDE M, Istl AC, Rogers CC, Cobb AN, et al
From Podium to PubMed: Successful Manuscript Publication of Oral Breast Surgery Abstract Presentations at National Meetings from 2017 to 2022.
Ann Surg Oncol. 2025;32:8184-8191.
PubMed Abstract available

AIELLO C, Eum JL, Smilen SH, Pandya D, et al
Is This the Right Link? How TikTok Views Oncoplastic Breast Surgery.
Ann Surg Oncol. 2025;32:8369-8373.
PubMed Abstract available

September 2025

TASHJIAN NL, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
ASO Visual Abstract: The Association of Clinical Stage at Presentation with Overall Survival in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18358.
PubMed

COBB AN, Dong X, Makope A, Cohen L, et al
Contemporary Nodal Management and Overall Survival of Older Patients with HR-/HER2+ Breast Cancer.
Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18417.
PubMed Abstract available

HAMID SA, Moses J, Lynch OF, Washington R, et al
Financial Outlook thRough CAncer STorytelling (FOReCAST): Development of a Novel Video-Based Storytelling Intervention to Mitigate Financial Hardship Among Young Women with Breast Cancer.
Ann Surg Oncol. 2025 Sep 24. doi: 10.1245/s10434-025-18405.
PubMed

DOUGLAS SR, van den Bruele AMB, Chiba A
ASO Author Reflections: Lessons Learned from Neoadjuvant Endocrine Therapy use for Estrogen Receptor Positive Breast Cancer during the Covid-19 Pandemic.
Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18380.
PubMed

MUNCK F, Tvedskov THF
Reply to "Comment on TAD Outcomes from the Danish Breast Cancer Group Database".
Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18419.
PubMed

DOUGLAS SR, Thomas SM, Chiba A, DiNome ML, et al
Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18225.
PubMed Abstract available

DOUGLAS SR, Thomas SM, van den Bruele AB, Wang T, et al
Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.
Ann Surg Oncol. 2025 Sep 20. doi: 10.1245/s10434-025-18307.
PubMed Abstract available

WAGNER BD, Rubin J, Boe LA, Diwan R, et al
Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy.
Ann Surg Oncol. 2025 Sep 19. doi: 10.1245/s10434-025-18334.
PubMed Abstract available

MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
ASO Visual Abstract: Medicaid Expansion Is Associated With Lower Mortality in Patients With Locally Advanced Breast Cancer.
Ann Surg Oncol. 2025 Sep 17. doi: 10.1245/s10434-025-18159.
PubMed

ARIMA J, Chida K, Wu R, Taniguchi K, et al
ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2- Breast Cancer: A New Role for ESR1?
Ann Surg Oncol. 2025 Sep 17. doi: 10.1245/s10434-025-18377.
PubMed

ARIMA J, Chida K, Wu R, Taniguchi K, et al
ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer.
Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18260.
PubMed Abstract available

MUNCK F, Jensen MB, Hawaz-Ali R, Tvedskov THF, et al
ASO Visual Abstract: Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection.
Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18256.
PubMed

ZATECKY J, Coufal O
De-escalation of Axillary Surgery in Inflammatory Breast Cancer: The Right Time is Coming.
Ann Surg Oncol. 2025 Sep 15. doi: 10.1245/s10434-025-18356.
PubMed

HUANG SY, Murray M, Rubio A, Okoro N, et al
Impact of Screening Mammography on Breast Cancer Outcomes in Women Aged 80 Years and Over.
Ann Surg Oncol. 2025 Sep 13. doi: 10.1245/s10434-025-18288.
PubMed Abstract available

JENSEN S, Tvedskov T, Bechmann T, Tramm T, et al
ASO Author Reflections: Is Axillary Lymph Node Dissection Always Justified for Residual Axillary Disease in Breast Cancer After Neoadjuvant Chemotherapy?
Ann Surg Oncol. 2025 Sep 12. doi: 10.1245/s10434-025-18302.
PubMed

AN SJ, Spanheimer PM
Reply to Letter to the Editor: "Reassessing Predictors of Nodal Pathologic Complete Response in Breast Cancer: Methodological Strengths and Data Gaps in the National Cancer Database Analysis," by Altundag.
Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18234.
PubMed

TEKCAN SANLI DE, Sanli AN
Comment on TAD Outcomes from the Danish Breast Cancer Group Database.
Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18318.
PubMed

SHOJAEIAN F, Vasigh M, Del Calvo H, Chaves LG, et al
Neoadjuvant Versus Adjuvant Therapy for Metaplastic Breast Cancer: Insights from the National Cancer Database-Is There a Winning Strategy?
Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-17937.
PubMed Abstract available

NELIS M, Chichura A, Al-Hilli Z
ASO Author Reflections: Reevaluating Treatment Sequence in Metaplastic Breast Cancer.
Ann Surg Oncol. 2025 Sep 9. doi: 10.1245/s10434-025-18316.
PubMed

TEKCAN SANLI DE, Sanli AN
Preoperative Radiation Boost in Early-Stage Breast Cancer: Effect on Re-excision and Complication Rates.
Ann Surg Oncol. 2025 Sep 6. doi: 10.1245/s10434-025-18322.
PubMed

KYEI I, Bea VJ, Gyan KK, Adjei E, et al
Oncologic Anthropology and the African Diaspora: Twenty-Year Anniversary Report, International Center for the Study of Breast Cancer Subtypes (ICSBCS).
Ann Surg Oncol. 2025 Sep 6. doi: 10.1245/s10434-025-17807.
PubMed Abstract available

LIN Y, Wang YY, Xu ZB, Dong L, et al
ASO Visual Abstract: miRNAs Associated with Axillary Lymph Node Metastasis in Breast Cancer: A Systematic Review and Meta-Analysis.
Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18205.
PubMed

MARIN C, Strawderman M, Peterson D, Cheng Z, et al
ASO Visual Abstract: Biology is Queen-The Oncotype DX 21-Gene Recurrence Score has Stronger Prognostic Ability than Lymph Node Burden for Patients with Breast Cancer.
Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18244.
PubMed

OROZCO JIJ, Valdez BJ, Trasatti ES, Brown SM, et al
Do Patients with DCIS or Invasive Breast Cancer Carry the Same Risk for Genetic Mutation?
Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18284.
PubMed

AN SJ, Thai CHNC, Agala CB, Abdou YG, et al
ASO Visual Abstract: Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18238.
PubMed

FUJINO S, Yamashita K, Okamoto R, Shibaki S, et al
ASO Visual Abstract: Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential.
Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18105.
PubMed

DE JESUS EM, Elmore LC, Fayanju OM
Annals of Surgical Oncology Landmark Series Disparities in Surgical Oncology: Breast Cancer.
Ann Surg Oncol. 2025 Sep 3. doi: 10.1245/s10434-025-18157.
PubMed Abstract available

THOMPSON D, Fefferman M, Simovic S, Kuchta K, et al
ASO Visual Abstract: Impact of Quality Improvement Interventions on Biopsy to Treatment Time in Breast Cancer-Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers.
Ann Surg Oncol. 2025 Sep 3. doi: 10.1245/s10434-025-18179.
PubMed

CHAKRABORTY MA, Haffty BG
ASO Author Reflections: Preoperative Radiation Boost Reduces Re-Excision Rate and Locoregional Treatment Time in Early-Stage Breast Cancer Patients.
Ann Surg Oncol. 2025 Sep 2. doi: 10.1245/s10434-025-18271.
PubMed

YUEN S, McCool K, Bharucha M, Narloch K, et al
ASO Visual Abstract: Evaluating Trends in Fertility Counseling Among Reproductive-Age Patients with Breast Cancer.
Ann Surg Oncol. 2025 Sep 2. doi: 10.1245/s10434-025-18129.
PubMed

LEVY J, Wagner BD, Roberts A, Shammas RL, et al
The Impact of Travel Distance on Patient Outcomes after Breast Reconstruction.
Ann Surg Oncol. 2025;32:6629-6639.
PubMed Abstract available

OU X, Liu Z, Liu C, Wang K, et al
Surgical and Oncologic Outcomes of Tumescence and Sharp Dissection Versus Electrocautery Dissection in Minimal-Access Nipple-Sparing Mastectomy with Immediate Prosthesis Breast Reconstruction: A Real-World Retrospective Cohort Study.
Ann Surg Oncol. 2025;32:6660-6670.
PubMed Abstract available

CHAKRABORTY MA, Sherwani ZK, Narra LR, Abou Yehia Z, et al
ASO Visual Abstract: Preoperative Radiation Boosts Results in Low Rates of Re-Excision and Reduced Locoregional Treatment Time for Breast Cancer Patients.
Ann Surg Oncol. 2025 Sep 1. doi: 10.1245/s10434-025-18245.
PubMed

August 2025

VAN HASSEL J, Dimitroff K, Yau C, Mukhtar R, et al
ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18131.
PubMed

CHU C, Goldman J, Joung H, Go S, et al
Breast Cancer Incidence Among Patients Undergoing Chest Masculinization Surgery: A Scoping Review.
Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18156.
PubMed Abstract available

VARMAN PM, Conner A, Bennett WC, Taft D, et al
ASO Visual Abstract: Impact of Second Opinions on Time to Treatment of Breast Cancer.
Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18180.
PubMed

YI M, Chavez-MacGregor M, Smith BD, Mitchell MP, et al
ASO Visual Abstract: Comparing Survival Differences Between Patients Undergoing Breast-Conserving Therapy Versus Total Mastectomy as a First Treatment for Early Stage Breast Cancer.
Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18217.
PubMed

REASON EH, Thomas SM, Chanenchuk T, Botty van den Bruele A, et al
ASO Visual Abstract: Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.
Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-18181.
PubMed

AMBURN T, Downs-Canner S
ASO Author Reflections: Nipple-Sparing Mastectomy for Breast Cancer Patients with Nipple Discharge.
Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18078.
PubMed

LYONS W, Fish EM, Bleicher RJ, Chang C, et al
Management and Outcomes in Patients with Breast Cancer with 1-of-1 and 2-of-2 Positive Sentinel Nodes.
Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18097.
PubMed Abstract available

NAASEH A, Tang SX, Maytin-Hevia AR, Wu N, et al
ASO Visual Abstract: Are Broadened Guidelines Improving Our Detection of Pathologic Genetic Mutations in Breast Cancer Patients? A 5-Year Comparative Analysis of American Society of Breast Surgeons and National Comprehensive Cancer Network Guidelines.
Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18182.
PubMed

SERRES SK, Saxon-Filipe S, Schwartz T
Complementary and Alternative Medicine in Breast Cancer: Considerations for the Breast Surgical Oncologist.
Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-17850.
PubMed Abstract available

VAN HASSEL J, Dimitroff K, Yau C, Mukhtar R, et al
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-17933.
PubMed Abstract available

MUKHTAR RA, Dimitroff K, Yau C, Chien AJ, et al
ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18104.
PubMed

VETTER CD, C Boughey J
ASO Author Reflections: Refining Prognostic Staging in De Novo Metastatic Breast Cancer: Validation, Limitations, and Future Directions.
Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18113.
PubMed

MOHAN SC, Chen JH, Tidwell RSS, Kai M, et al
ASO Visual Abstract: Investigating the Prognostic Impact of Postpartum Diagnosis in Women with De Novo Stage IV Inflammatory Breast Cancer.
Ann Surg Oncol. 2025 Aug 21. doi: 10.1245/s10434-025-18098.
PubMed

CHAKRABORTY MA, Sherwani ZK, Narra LR, Abou Yehia Z, et al
Preoperative Radiation Boost Results in Low Rates of Re-excision and Reduced Locoregional Treatment Time in Breast Cancer Patients.
Ann Surg Oncol. 2025 Aug 20:10.1245/s10434-025-18089.
PubMed Abstract available

TASHJIAN NL, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
ASO Author Reflections: Survival of Patients with HER2-Positive Breast Cancer After Neoadjuvant Chemotherapy Based on Presenting Clinical Stage and Response to Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18188.
PubMed

MARIN C, Strawderman M, Peterson D, Cheng Z, et al
Biology is Queen: The Oncotype DX 21-Gene Recurrence Score Has Stronger Prognostic Ability than Lymph Node Burden for Patients with Breast Cancer.
Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18086.
PubMed Abstract available

MUNCK F, Jensen MB, Hawaz-Ali R, Tvedskov THF, et al
Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection.
Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18068.
PubMed Abstract available

CHICHURA AM, Chen X, Nelis M, Kopicky L, et al
Neoadjuvant Chemotherapy is Associated with Worse 5-Year Overall Survival in Patients with Metaplastic Breast Cancer Compared with Primary Surgery: A National Cancer Database Analysis.
Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18085.
PubMed Abstract available

MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
ASO Author Reflections: Medicaid's Impact on Breast Cancer.
Ann Surg Oncol. 2025 Aug 19. doi: 10.1245/s10434-025-18107.
PubMed

GHASEMI F, Young J, Asaoka M, Takabe K, et al
ASO Author Reflections: Refining Breast Cancer Staging to More Accurately Reflect Disease Biology.
Ann Surg Oncol. 2025 Aug 19. doi: 10.1245/s10434-025-18167.
PubMed

TASHJIAN NL, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
The Association of Clinical Stage at Presentation with Overall Survival of Patients who have HER2-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2025 Aug 14. doi: 10.1245/s10434-025-18050.
PubMed Abstract available

LEE EG, Lee DE, Jung SY, Han JH, et al
ASO Author Reflections: Multimodal Sentinel Lymph Node Mapping in Breast Cancer: Efficacy and Clinical Implications After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2025 Aug 12. doi: 10.1245/s10434-025-18053.
PubMed

YI M, Chavez-MacGregor M, Smith BD, Mitchell MP, et al
Comparing Survival Differences between Patients Undergoing Breast-Conserving Therapy Versus Total Mastectomy as a First Treatment for Early Stage Breast Cancer.
Ann Surg Oncol. 2025 Aug 11:10.1245/s10434-025-18030.
PubMed Abstract available

THOMPSON D, Fefferman M, Simovic S, Kuchta K, et al
Impact of Quality Improvement Interventions on Biopsy-to-Treatment Time in Breast Cancer: Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers.
Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-17935.
PubMed Abstract available

KERIVAN L, Wagner J, Nye L, Balanoff C, et al
ASO Visual Abstract: Surgical Choice Among Women with a First Breast Cancer and Pathogenic Variants in Breast Cancer Genes.
Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-18071.
PubMed

LIN Y, Wang YY, Xu ZB, Dong L, et al
miRNAs Associated with Axillary Lymph Node Metastasis in Breast Cancer: A Systematic Review and Meta-Analysis.
Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-17983.
PubMed Abstract available

STARI OL, Torok C, Gorog PO, Markus B, et al
ASO Author Reflections: The Completion May Lead to Conservation: Partial and Complete Intraoperative Ultrasound Enhanced Breast-Conserving Surgery for Invasive Breast Cancer.
Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18009.
PubMed

LIN Y, Wang YY, Xu ZB, Dong L, et al
ASO Author Reflections: MicroRNAs as Predictive Biomarkers for Axillary Lymph Node Metastasis in Breast Cancer.
Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18075.
PubMed

KERIVAN LT, Larson KE
ASO Author Reflections: Unilateral Cancer, Bilateral Decisions: Contralateral Risk-Reducing Mastectomy Performance in Patients with a First Breast Cancer and Positive Genetic Testing.
Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18016.
PubMed

NAASEH A, Margenthaler JA
ASO Author Reflections: Moving Beyond Risk-Based Genetic Testing Criteria: Supporting Universal Genetic Testing in Breast Cancer Patients.
Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18074.
PubMed

CHEN SL, Shah C, Boyages J, Koelmeyer L, et al
ASO Visual Abstract: The Importance of a Pretreatment Baseline When Screening Patients for Breast-Cancer-Related Lymphedema.
Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18062.
PubMed

BLEICHER RJ
ASO Author Reflections: The Worried Waiting-Breast Cancer Upstaging and In Vivo Growth During Preoperative Delays.
Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18008.
PubMed

EDWARDS M, Elder K, Rose A, Tan E, et al
ASO Visual Abstract: Survival Benefits and Less Intensive Treatment for Women Diagnosed with Early-Stage Breast Cancer While Participating in Population-Based Screening.
Ann Surg Oncol. 2025 Aug 7. doi: 10.1245/s10434-025-18069.
PubMed

MANN GB
ASBrS Keynote Address: Reimagining Stage 1 Breast Cancer-Evolution of Breast Cancer Management over the Last 120 Years.
Ann Surg Oncol. 2025 Aug 7. doi: 10.1245/s10434-025-17849.
PubMed

CHEN JH, Warneke CL, Middleton L, Singh P, et al
ASO Visual Abstract: Complication Rates Are Low After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy.
Ann Surg Oncol. 2025 Aug 7. doi: 10.1245/s10434-025-18064.
PubMed

BRENNAN MA, Plichta JK, Rozenblit M, Flanagan MR, et al
Surgeon Attitudes on the Management of de novo Oligometastatic Breast Cancer.
Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-17912.
PubMed

FUJINO S, Yamashita K, Okamoto R, Shibaki S, et al
Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential.
Ann Surg Oncol. 2025 Aug 5. doi: 10.1245/s10434-025-17944.
PubMed Abstract available

LUBARSKY M, Hernandez AE, Borowsky PA, Thompson C, et al
A Comprehensive Analysis of Unmet Social Needs in Breast Cancer Patients Treated at an Academic Cancer Center and Sister Safety-Net Hospital.
Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17609.
PubMed Abstract available

ALTUNDAG K
Reassessing Predictors of Nodal Pathologic Complete Response in Breast Cancer: Methodological Strengths and Data Gaps in the National Cancer Database.
Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-18055.
PubMed

CHEN JC, Handley D, Elsaid MI, Carson WE, et al
Omitting Sentinel Lymph Node Biopsy in Small Hormone Receptor-Positive Breast Cancer: Does Race Matter?
Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-18038.
PubMed

LEE EG, Lee DE, Jung SY, Han JH, et al
ASO Visual Abstract: Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Final Analysis.
Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17961.
PubMed

LUBARSKY M, Hernandez AE, Borowsky PA, Thompson C, et al
ASO Visual Abstract: A Comprehensive Analysis of Unmet Social Needs in Patients with Breast Cancer Treated at an Academic Cancer Center and Sister Safety-Net Hospital.
Ann Surg Oncol. 2025 Aug 3. doi: 10.1245/s10434-025-17720.
PubMed

VARMAN PM, Conner A, Bennett WC, Taft D, et al
Impact of Second Opinions on Time to Treatment of Breast Cancer.
Ann Surg Oncol. 2025 Aug 2. doi: 10.1245/s10434-025-17934.
PubMed Abstract available

SHAHEEN MS, Necker FN, Momeni A
National Trends and Impact of Preoperative CT-Angiography on Autologous Breast Reconstruction.
Ann Surg Oncol. 2025;32:5838-5844.
PubMed Abstract available

SCHUMACHER JR, Hanlon BM, Zahrieh D, Rathouz PJ, et al
Impact of a Web-Based Decision Aid on Socioeconomically Disadvantaged Patients' Engagement in Breast Surgery Decision-Making: Stepped-Wedge Clinical Trial (Alliance-A231701CD).
Ann Surg Oncol. 2025;32:5540-5550.
PubMed Abstract available

GOOCH JC, McClelland QY, Paschalis K, Dobbins J, et al
Same Day Discharges Among Elderly Mastectomy Patients: A Single Institution Prospective Study.
Ann Surg Oncol. 2025;32:5521-5527.
PubMed Abstract available

MUELLER C, Rangan R, Kruse M, Al-Hilli Z, et al
Trends in the Management of Small HER2-Positive Breast Cancers.
Ann Surg Oncol. 2025;32:5510-5520.
PubMed Abstract available

CAVALCANTE FP, de Oliveira VM, Ziegelmann PK, Brenelli FP, et al
National Survey on Attitudes of Brazilian Breast Surgeons Regarding Oncoplastic Surgery: Success of a Training Model.
Ann Surg Oncol. 2025;32:5489-5499.
PubMed Abstract available

HUYNH VD, Mouabbi J, Kuerer HM, Wanis KN, et al
Characterization of the Germline Pathogenic Mutational Landscape and Oncologic Outcomes Among 877 Patients with Invasive Lobular Carcinoma.
Ann Surg Oncol. 2025;32:5477-5488.
PubMed Abstract available

NAPIERALA MJ, Olszewski W, Rosinska M, Okarska-Napierala M, et al
Residual Breast Tissue After Four Types of Mastectomy: A Prospective, Comparative Study.
Ann Surg Oncol. 2025;32:5467-5476.
PubMed Abstract available

SOROUDI D, Parmeshwar N, Gozali A, Piper M, et al
Post-Mastectomy Flat Closure: A Mixed-Methods Analysis of Patient Outcomes and Perspectives.
Ann Surg Oncol. 2025;32:5827-5837.
PubMed Abstract available

HASSAN AM, Hajj JP, Lewis JP, Ahmed S, et al
Long-Term Outcomes of Lymphedema After Immediate Lymphatic Reconstruction Following Axillary Lymph Node Dissection.
Ann Surg Oncol. 2025;32:5817-5826.
PubMed Abstract available

July 2025

MARTIN G, Kensler KH, Tamimi RM, Bea VJ, et al
ASO Author Reflections: Reconstructing Equity: Policy's Role in Post-Mastectomy Breast Cancer Care.
Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17941.
PubMed

YAO J
ASO Author Reflections: Prospective Validation of Lymphatic Contrast-Enhanced Ultrasound for Non-invasive Sentinel Lymph Node Assessment in Breast Cancer.
Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17761.
PubMed

MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
Medicaid Expansion Is Associated with Lower Mortality in Patients with Locally Advanced Breast Cancer.
Ann Surg Oncol. 2025 Jul 30. doi: 10.1245/s10434-025-17865.
PubMed Abstract available

PRATT CG, McClelland PH, Long SA, Moore AN, et al
The Metaplastic Conundrum: A National Cancer Database Analysis of Metaplastic versus Triple-Negative Ductal Breast Cancer.
Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17932.
PubMed Abstract available

VETTER CD, Hoskin T, Olson C, Giridhar K, et al
Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of Performance for Cancer-Specific Outcomes.
Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17863.
PubMed Abstract available

REASON EH, Thomas SM, Chanenchuk T, Botty van den Bruele AM, et al
Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.
Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17938.
PubMed Abstract available

CHAN K, Yao K
ASO Author Reflections: Leveraging Cancer Accreditation Standards to Improve the Delivery of Breast Cancer Care.
Ann Surg Oncol. 2025 Jul 28. doi: 10.1245/s10434-025-17956.
PubMed

KERIVAN L, Wagner J, Nye L, Balanoff C, et al
Surgical Choice among Women with a First Breast Cancer and Pathogenic Variants in Breast Cancer Genes.
Ann Surg Oncol. 2025 Jul 27. doi: 10.1245/s10434-025-17859.
PubMed Abstract available

EDWARDS M, Elder K, Rose A, Tan E, et al
Survival Benefits and Less Intensive Treatment for Women with Early-Stage Breast Cancer Diagnosed While Participating in Population-Based Screening.
Ann Surg Oncol. 2025 Jul 25. doi: 10.1245/s10434-025-17845.
PubMed Abstract available

MOHAN SC, Johnson HM
ASO Author Reflections: Postpartum Diagnosis of Stage IV Inflammatory Breast Cancer.
Ann Surg Oncol. 2025 Jul 25. doi: 10.1245/s10434-025-17958.
PubMed

STARI OL, Torok C, Gorog PO, Kovacs B, et al
May the Completion Lead to Conservation: Impact of Partial and Complete Intraoperative Ultrasound Application on Resection Margin Management During Breast-Conserving Surgery for Invasive Breast Cancer: A Retrospective Cohort Study.
Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17822.
PubMed Abstract available

YUEN S, McCool K, Bharucha M, Narloch K, et al
Evaluating Trends in Fertility Counseling among Reproductive-Age Patients with Breast Cancer.
Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17857.
PubMed Abstract available

MUKHTAR RA, Dimitroff K, Yau C, Chien AJ, et al
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17862.
PubMed Abstract available

MOHAN SC, Chen JH, Tidwell RSS, Kai M, et al
Investigating the Prognostic Impact of Postpartum Diagnosis in Women with De Novo Stage IV Inflammatory Breast Cancer.
Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17855.
PubMed Abstract available

BLEICHER RJ, Ruth KJ, Williams AD, Ross EA, et al
Breast Cancer Upstaging Risk and In Vivo Tumor Growth Rates Associated with Preoperative Delays.
Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17867.
PubMed Abstract available

CHEN SL, Shah C, Boyages J, Koelmeyer L, et al
The Importance of a Pre-treatment Baseline When Screening Patients for Breast-Cancer-Related Lymphedema.
Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17854.
PubMed Abstract available

NAASEH A, Tang SX, Maytin-Hevia AR, Wu N, et al
Are Broadened Guidelines Improving our Detection of Pathologic Genetic Mutations in Breast Cancer Patients? A 5-Year Comparative Analysis of American Society of Breast Surgeons and National Comprehensive Cancer Network Guidelines.
Ann Surg Oncol. 2025 Jul 22. doi: 10.1245/s10434-025-17939.
PubMed Abstract available

OSHI M, Ghasemi F, Yamada A, Zhang J, et al
ASO Author Reflections: Reframing Hippo Pathway Activation as a Prognostic and Predictive Biomarker in HER2-Positive Breast Cancer.
Ann Surg Oncol. 2025 Jul 22. doi: 10.1245/s10434-025-17875.
PubMed

JONES M, Alsafwani ZW, Orozco JIJ, Lele SM, et al
Pre-Treatment Tumor Collagen is Associated with Triple-Negative Breast Cancer Pathological Response to Chemo-Immunotherapy.
Ann Surg Oncol. 2025 Jul 21. doi: 10.1245/s10434-025-17904.
PubMed

AN SJ, Thai CHNC, Agala CB, Abdou YG, et al
Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
Ann Surg Oncol. 2025 Jul 19. doi: 10.1245/s10434-025-17906.
PubMed Abstract available

CHEN JH, Warneke CL, Middleton L, Singh P, et al
Complication Rates are Low After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy.
Ann Surg Oncol. 2025 Jul 17. doi: 10.1245/s10434-025-17856.
PubMed Abstract available

TAPIAVALA S, Liu Y, Roy S, Hensing W, et al
Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast Cancer.
Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17448.
PubMed Abstract available

JOHNSON HM, Mitchell KB
ASO Author Reflections: Oncolactation Guidelines for Patients with Breast Cancer.
Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17793.
PubMed

VICINI FA
Intraoperative Radiation Therapy for Early-Stage Breast Cancer: Promise or Peril?
Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17785.
PubMed

JOHNSON HM, Miller ME, Mitchell KB
Oncolactation for Patients with Breast Cancer: Executive Summary from the American Society of Breast Surgeons.
Ann Surg Oncol. 2025 Jul 8. doi: 10.1245/s10434-025-17742.
PubMed Abstract available

KNOEDLER S, Jiang J, Moog P, Wirtz JM, et al
ASO Visual Abstract: Predicting Outcomes of Breast-Conserving Surgery in Breast Cancer Patients Using the Modified 5-Item Frailty Index-A Retrospective Cohort Study.
Ann Surg Oncol. 2025 Jul 5. doi: 10.1245/s10434-025-17625.
PubMed

KEEGAN G, Ravenell J, Crown A, DiMaggio C, et al
Impact of Unmet Social Needs on Access to Breast Cancer Screening and Treatment: An Analysis of Barriers Faced by Patients in a Breast Cancer Navigation Program.
Ann Surg Oncol. 2025 Jul 2. doi: 10.1245/s10434-025-17608.
PubMed Abstract available

CHIARELLA LS, Huelsboemer L, Diatta F, Klimitz FJ, et al
The Five-Item Modified Frailty Index Predicts Adverse Surgical Outcomes in Patients Undergoing Mastectomy.
Ann Surg Oncol. 2025;32:4829-4837.
PubMed Abstract available

SWITALLA KM, Falade IO, Quirarte A, Baxter M, et al
Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery.
Ann Surg Oncol. 2025;32:4899-4909.
PubMed Abstract available

TAYLOR CD, Wang T, Sinco BR, Pilewskie M, et al
National Variation in Implementation of Sentinel Lymph Node Biopsy for Clinically Node-Positive Patients Undergoing Neoadjuvant Therapy.
Ann Surg Oncol. 2025;32:4874-4882.
PubMed Abstract available

KEEGAN G, Ravenell J, Crown A, DiMaggio C, et al
ASO Visual Abstract: Impact of Unmet Social Needs on Access to Breast Cancer Screening and Treatment: An Analysis of Barriers Faced by Patients in a Breast Cancer Navigation Program.
Ann Surg Oncol. 2025 Jul 1. doi: 10.1245/s10434-025-17716.
PubMed

June 2025

LEE EG, Lee DE, Jung SY, Han JH, et al
Clinical Application of Multimodal Sentinel Lymph Node-Mapping Method for Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Final Analysis.
Ann Surg Oncol. 2025 Jun 30. doi: 10.1245/s10434-025-17740.
PubMed Abstract available

HOSANG KM, Bleicher RJ, Yao KA, Dietz JR, et al
ASO Visual Abstract: Low Socioeconomic Status at the Patient and Institutional Level Impact Achievement of Breast Cancer Quality Standards.
Ann Surg Oncol. 2025 Jun 29. doi: 10.1245/s10434-025-17690.
PubMed

SILVERSTEIN MJ, Kim B, Lin K, Lloyd S, et al
ASO Visual Abstract: Intraoperative Radiation Therapy (IORT) for Breast Cancer: The Final Analysis of a Prospective Cohort of 1828 Cases.
Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17698.
PubMed

NGUYEN CL, Poels D, Teoh B, Rastogi P, et al
Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph Node Dissection in Breast Cancer: The FARM Trial.
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17703.
PubMed Abstract available

NIERENBERG TC, Plichta JK
ASO Author Reflections: Adjuvant Therapy Options for Older Women with Early Stage Breast Cancer.
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17732.
PubMed

HSIEH YC, Huang CS, Chan YH
A Dose-Image Optimization Trial for Voluven(R)-Assisted Indocyanine Green Fluorescence-Guided Breast Cancer Sentinel Lymph Node Surgery.
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17696.
PubMed Abstract available

YAO J, Li H, Wang H, Liu B, et al
Lymphatic Contrast-enhanced Ultrasound as a Noninvasive Predictor of Sentinel Lymph Node Metastasis in Breast Cancer: A Prospective Diagnostic Study.
Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17705.
PubMed Abstract available

OSHI M, Ghasemi F, Yamada A, Yan L, et al
Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast Cancer.
Ann Surg Oncol. 2025 Jun 21. doi: 10.1245/s10434-025-17657.
PubMed Abstract available

JANSEN BAM, Kelder JC, Borchert T, van Uden DJP, et al
Trends in Surgical Treatment for cT4 Breast Cancer After Neoadjuvant Systemic Therapy: A Nationwide Study in The Netherlands.
Ann Surg Oncol. 2025 Jun 18. doi: 10.1245/s10434-025-17585.
PubMed Abstract available

KNOEDLER S, Jiang J, Moog P, Wirtz JM, et al
ASO Author Reflections: Frailty as a Predictor in Breast Cancer Surgery: Yesterday's Lessons, Today's Evidence, Tomorrow's Potential.
Ann Surg Oncol. 2025 Jun 17. doi: 10.1245/s10434-025-17604.
PubMed

HOLT LR, Shern TP, Ozmen T
ASO Author Reflections: Personalizing Tumor Size Assessment in Breast Cancer-A Framework for Dynamic, Patient-Centered Estimation.
Ann Surg Oncol. 2025 Jun 17. doi: 10.1245/s10434-025-17701.
PubMed

KOHLI K, Wang S, Thaploo A, Ho FDV, et al
ASO Author Reflections: Breast Cancer Among Asian American, Native Hawaiian, and Pacific Islander Patients.
Ann Surg Oncol. 2025 Jun 16. doi: 10.1245/s10434-025-17510.
PubMed

JUNG JJ, Kim HC, Kang E, Kim HK, et al
Refining Criteria for Axillary Surgery Omission After Neoadjuvant Systemic Therapy in Breast Cancer.
Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17618.
PubMed

YOON IC, Perez-Rojas S, Ancha B, Elmore LC, et al
ASO Visual Abstract: Association of Neighborhood Deprivation with Stage at Diagnosis and Treatment Delay for Breast Cancer in Philadelphia.
Ann Surg Oncol. 2025 Jun 11. doi: 10.1245/s10434-025-17524.
PubMed

AHMED S, Manghelli J, Fisher CS, Imeokparia FO, et al
Effect of Delayed Axillary Lymph Node Dissection on Success Rates of Immediate Lymphatic Reconstruction in Breast Cancer.
Ann Surg Oncol. 2025 Jun 10. doi: 10.1245/s10434-025-17641.
PubMed

THILL M, Ghilli M, Roncella M, Kelling K, et al
ASO Visual Abstract: Multi-Institutional Study to Evaluate the Effectiveness and Safety of a Supine MRI-Based Guidance System, the Breast Cancer Locator(TM), for Breast-Conserving Surgery in Patients with Nonpalpable Breast Cancer.
Ann Surg Oncol. 2025 Jun 9. doi: 10.1245/s10434-025-17622.
PubMed

EAGLEHOUSE YL, Darmon S, Nealeigh M, Koehlmoos T, et al
ASO Visual Abstract: Short-Term Outcomes of Breast Cancer Surgery by Race-Ethnicity in the Military Health System.
Ann Surg Oncol. 2025 Jun 7. doi: 10.1245/s10434-025-17628.
PubMed

NIERENBERG TC, Crowell KA, Wang T, Rosenberger LH, et al
ASO Visual Abstract: Adjuvant Radiation Versus Endocrine Therapy After Lumpectomy for Early Stage Breast Cancer in Older Women-Analysis of Real-World Survival Outcomes.
Ann Surg Oncol. 2025 Jun 7. doi: 10.1245/s10434-025-17624.
PubMed

THILL M, Ghilli M, Roncella M, Kelling K, et al
A Multi-institutional Study to Evaluate the Effectiveness and Safety of a Supine MRI-Based Guidance System, the Breast Cancer Locator(TM), for Breast Conserving Surgery in Patients with Nonpalpable Breast Cancer.
Ann Surg Oncol. 2025 Jun 6. doi: 10.1245/s10434-025-17513.
PubMed Abstract available

NIERENBERG TC, Crowell KA, Wang T, Rosenberger LH, et al
Adjuvant Radiation vs Endocrine Therapy After Lumpectomy for Early-Stage Breast Cancer in Older Women: Analysis of Real-World Survival Outcomes.
Ann Surg Oncol. 2025 Jun 6. doi: 10.1245/s10434-025-17532.
PubMed Abstract available

FLANAGAN MR, van den Bruele AMB, Downs-Canner SM, Thomas SM, et al
ASO Visual Abstract: A Multi-institutional Analysis of Contralateral Axillary Metastases-Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.
Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17563.
PubMed

HOSANG KM, Bleicher RJ, Yao KA, Dietz JR, et al
Low Socioeconomic Status at the Patient and Institutional Level Impact Achievement of Breast Cancer Quality Standards.
Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17529.
PubMed Abstract available

VAN DEN BRUELE AB, Rosenberger LH, Downs-Canner S, Flanagan MR, et al
ASO Author Reflections: Contralateral Axillary Lymph Node Metastasis of Breast Cancer: Time to Re-evaluate Conventional Thinking.
Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17535.
PubMed

LAVA CX, Harish V, Kapp K, Li KR, et al
Utility of Surgical Axillary Staging in Microinvasive Ductal Carcinoma In Situ: A National Cancer Database Analysis.
Ann Surg Oncol. 2025;32:4023-4033.
PubMed Abstract available

BHADOURIYA R, Mantena RV, Selvakumar JP, Yadav P, et al
Disparities in Refusal of Adjuvant Radiation for Breast-Conserving Therapy in the USA.
Ann Surg Oncol. 2025;32:4034-4040.
PubMed Abstract available

WEISS A, Rosito MS, Braun D, Barton B, et al
Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy Rates.
Ann Surg Oncol. 2025;32:3965-3974.
PubMed Abstract available

KIM E, Dossett LA, Hughes TM, Jeruss JS, et al
The Effectiveness of Superparamagnetic Iron Oxide Nanoparticles in Reducing Unnecessary Sentinel Lymph Node Biopsies.
Ann Surg Oncol. 2025;32:4017-4022.
PubMed Abstract available

SPAULDING S, Orzechowski K, Patek K
Integration of a Genetic Counselor into a Breast Health Center Improves Identification of Patients Needing Genetic Testing.
Ann Surg Oncol. 2025;32:4002-4007.
PubMed Abstract available

NGUYEN AT, Duckworth E, Kandi L, Li RA, et al
Disparities in Postmastectomy Breast Reconstruction Among American Indian and Alaska Native Women: A Systematic Literature Review and Meta-analysis.
Ann Surg Oncol. 2025;32:4041-4052.
PubMed Abstract available

May 2025

SAH R, Mathur A, Veldi VDK
Letter to the Editor Regarding "Differential Effects of Endocrine Therapy Type on Quality of Life in Older (>/= 70 Years) Women with Early-Stage Breast Cancer".
Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17593.
PubMed

SILVERSTEIN MJ, Kim B, Lin K, Lloyd S, et al
Intraoperative Radiation Therapy (IORT) for Breast Cancer: The Final Analysis of a Prospective Cohort of 1828 Cases.
Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17546.
PubMed Abstract available

ORSI C, Davis T, Swindall R, Wadle C, et al
ASO Visual Abstract: Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting; Rural Breast Cancer Treatment Disparities.
Ann Surg Oncol. 2025 May 30. doi: 10.1245/s10434-025-17476.
PubMed

WEISS A, Agnese DM, Al-Hilli Z, Cabioglu N, et al
Correction: An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients: From the Society of Surgical Oncology and the American Society of Breast Surgeons.
Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-025-17580.
PubMed

EAGLEHOUSE YL, Darmon S, Nealeigh M, Koehlmoos T, et al
Short-Term Outcomes of Breast Cancer Surgery by Race-Ethnicity in the Military Health System.
Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-025-17449.
PubMed Abstract available

FLANAGAN MR, van den Bruele AMB, Downs-Canner SM, Thomas SM, et al
A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.
Ann Surg Oncol. 2025 May 20. doi: 10.1245/s10434-025-17406.
PubMed Abstract available

WU C, Zhao H, Di H, Cheng K, et al
ASO Author Reflections: Global Research Status of Breast Cancer Stem Cells.
Ann Surg Oncol. 2025 May 17. doi: 10.1245/s10434-025-17457.
PubMed

ZOU Y, Bian L, Zhang H, Tang H, et al
ASO Author Reflections: Limited Survival Benefit from Neoadjuvant Chemotherapy in ER+/HER2- Breast Cancer.
Ann Surg Oncol. 2025 May 17. doi: 10.1245/s10434-025-17408.
PubMed

KNOEDLER S, Jiang J, Moog P, Wirtz JM, et al
Predicting Outcomes of Breast-Conserving Surgery in Patients with Breast Cancer Using the Modified 5-Item Frailty Index: A Retrospective Cohort Study.
Ann Surg Oncol. 2025 May 16. doi: 10.1245/s10434-025-17438.
PubMed Abstract available

WEISS A, Agnese DM, Al-Hilli Z, Cabioglu N, et al
An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients.
Ann Surg Oncol. 2025 May 12. doi: 10.1245/s10434-025-17405.
PubMed

YOON IC, Perez-Rojas S, Ancha B, Elmore LC, et al
Association of Neighborhood Deprivation with Stage at Diagnosis and Treatment Delay for Breast Cancer in Philadelphia.
Ann Surg Oncol. 2025 May 12. doi: 10.1245/s10434-025-17367.
PubMed Abstract available

KOUZMINA E, Castelo M, Look Hong NJ, Hallet J, et al
ASO Visual Abstract: Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer-Population-Based Trends over Time.
Ann Surg Oncol. 2025 May 10. doi: 10.1245/s10434-025-17423.
PubMed

DENNIS S, Tsukioki T, Kocherginsky M, Qi AK, et al
ASO Visual Abstract: Neoadjuvant Chemotherapy Response and Genetic Susceptibility in Recently Parous Women with Breast Cancer: A Retrospective Analysis.
Ann Surg Oncol. 2025 May 8. doi: 10.1245/s10434-025-17370.
PubMed

CHO MJ, Chratian S, Hansotia K, Skoracki R, et al
Reply to: "Prophylactic Lymphovenous Bypass for Breast Cancer-Related Lymphedema: Research Challenges, Statistical Pitfalls, and Solutions".
Ann Surg Oncol. 2025 May 2. doi: 10.1245/s10434-025-17377.
PubMed

ROBERTS A, Campbell AC, Pollack BL, Montagna G, et al
Racial and Ethnic Differences in Breast Inflammation and Its Association with Lymphedema Risk After Axillary Lymph Node Dissection.
Ann Surg Oncol. 2025;32:3309-3316.
PubMed Abstract available

WARREN YE JR, Stead TS, Tomlinson-Hansen S, Stuckey AR, et al
Outcomes in Women Undergoing Combined Breast, Plastic, and Gynecologic Surgery.
Ann Surg Oncol. 2025;32:3302-3308.
PubMed Abstract available

ZAVERI S, Sun SX, Zaghloul T, Bevers TB, et al
Trends in Atypical Ductal Hyperplasia Diagnosis and Upgrade: A 20-Year Experience and Impact of MRI Use on Upgrade Rates.
Ann Surg Oncol. 2025;32:3244-3251.
PubMed Abstract available

JAVID SH, Kazerouni AS, Hippe DS, Hirano M, et al
Preoperative MRI to Predict Upstaging of DCIS to Invasive Cancer at Surgery.
Ann Surg Oncol. 2025;32:3234-3243.
PubMed Abstract available

TAKAYESU JSK, Baglien B, Edwards D, Marsh R, et al
Effect of Prepectoral Versus Subpectoral Implant-Based Reconstruction on Post-Mastectomy Radiation Dosimetry.
Ann Surg Oncol. 2025;32:3705-3712.
PubMed Abstract available

ROCHLIN DH, Wang Y, Amakiri UO, Levy J, et al
Lower Commercial Rates for Breast Surgical Procedures are Associated with Socioeconomic Disadvantage: A Transparency in Coverage Analysis.
Ann Surg Oncol. 2025;32:3695-3704.
PubMed Abstract available

April 2025

LI K, Moshier E, Shao T, Rosenstein BS, et al
Differential Effects of Endocrine Therapy Type on Quality of Life in Older (>/=70 Years) Women with Early-Stage Breast Cancer.
Ann Surg Oncol. 2025 Apr 26. doi: 10.1245/s10434-024-16482.
PubMed Abstract available

SATO T, Hagerty BL, Wu R, Ishikawa T, et al
ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer?
Ann Surg Oncol. 2025 Apr 24. doi: 10.1245/s10434-025-17314.
PubMed

CHENG K, Di H, Wu C, Zhao H, et al
Mapping Knowledge Landscapes and Themes Trends of Breast Cancer Stem Cells: A Comprehensive Data-Mining-Based Study.
Ann Surg Oncol. 2025 Apr 23. doi: 10.1245/s10434-025-17336.
PubMed Abstract available

WANG J, Yang B, Bian L, Zhang H, et al
Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in ER+/HER2- Locally Advanced Breast Cancer.
Ann Surg Oncol. 2025 Apr 22. doi: 10.1245/s10434-025-17297.
PubMed Abstract available

DOUGLAS SR, Margenthaler JA, McGuire KP, Hwang ES, et al
Great Debate: Does Breast-Conserving Surgery with Radiotherapy Offer Better Survival than Mastectomy in Early-Stage Breast Cancer?
Ann Surg Oncol. 2025 Apr 21. doi: 10.1245/s10434-025-17333.
PubMed

HAGERTY BL, Sato T, Wu R, Ishikawa T, et al
ASO Visual Abstract: Mesothelin (MSLN) is Highly Expressed in Triple-Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Pro-inflammatory Tumor Microenvironment.
Ann Surg Oncol. 2025 Apr 21. doi: 10.1245/s10434-025-17253.
PubMed

BOYLE MK, Giuliano AE
ASO Author Reflections: Advances in Axillary Management for Breast Cancer After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2025 Apr 20. doi: 10.1245/s10434-025-17340.
PubMed

ORSI C, Davis T, Swindall R, Wadle C, et al
Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting: Breast Cancer Treatment Disparities.
Ann Surg Oncol. 2025 Apr 17. doi: 10.1245/s10434-025-17291.
PubMed Abstract available

DENNIS S, Tsukioki T, Kocherginsky M, Qi AK, et al
Neoadjuvant Chemotherapy Response and Genetic Susceptibility in Recently Parous Women with Breast Cancer: A Retrospective Analysis.
Ann Surg Oncol. 2025 Apr 9. doi: 10.1245/s10434-025-17204.
PubMed Abstract available

KOUZMINA E, Castelo M, Look Hong NJ, Hallet J, et al
Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Population-Based Trends Over Time.
Ann Surg Oncol. 2025 Apr 4. doi: 10.1245/s10434-025-17236.
PubMed Abstract available

CHIARELLA LS, Huelsboemer L, Diatta F, Klimitz FJ, et al
ASO Author Reflections: The Five-Item Modified Frailty Index in Breast Cancer Surgery: Past Insights, Present Evidence, and Future Directions.
Ann Surg Oncol. 2025 Apr 4. doi: 10.1245/s10434-025-17273.
PubMed

PERRY LM, Sevilimedu V, Polidorio N, Abuhadra N, et al
ASO Visual Abstract: Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.
Ann Surg Oncol. 2025 Apr 2. doi: 10.1245/s10434-025-17248.
PubMed

PASCHALIS K, Marin C, Miller K, Regis C, et al
Patients with DCIS Seen at a Specialized High-Risk Breast Clinic Run by Surgical Advanced Practice Providers Have High Rates of Preventive Medication Uptake.
Ann Surg Oncol. 2025;32:2526-2533.
PubMed Abstract available

SWAFFORD EP, Anantha S, Davis J, Heath R, et al
Lumpectomy Patients are at Highest Risk for Opioid Overprescription: A Comparison Between Practice Patterns and OPEN National Guidelines.
Ann Surg Oncol. 2025;32:2585-2593.
PubMed Abstract available

NAKHLIS F, Baker GM, Li T, McAuliffe PF, et al
Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034).
Ann Surg Oncol. 2025;32:2578-2584.
PubMed Abstract available

VERDIAL FC, Anderman KJ, Daly AE, Ozmen T, et al
The Age-Old Question in Nipple-Sparing Mastectomy: Is Older Age a Contraindication?
Ann Surg Oncol. 2025;32:2569-2577.
PubMed Abstract available

MEURS CJC, Kerkhoven C, Siesling S, Menke-Pluijmers MBE, et al
Surgery for Classic, Pleomorphic and Non-classic Lobular Carcinoma In Situ: Surgery Rate, Risk of Upstaging and Short-Term Follow-Up.
Ann Surg Oncol. 2025;32:2545-2553.
PubMed Abstract available

CHEN Z, Zhang J, Chen W, Chen X, et al
ASO Author Reflections: Serum Enzymes as Predictive Biomarkers for Pathologic Complete Response in HER2-Positive Breast Cancer.
Ann Surg Oncol. 2025 Apr 1. doi: 10.1245/s10434-025-17259.
PubMed

March 2025

BOYLE MK, Amersi F, Chung A, Tseng J, et al
Comparison of Targeted Axillary Dissection with Sentinel Node Biopsy Alone on Nodal Recurrence for Patients who have Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2025 Mar 25. doi: 10.1245/s10434-025-17197.
PubMed Abstract available

THAPLOO A, Kohli K, Wang S, Ho FDV, et al
ASO Visual Abstract: Disparities in Stage at Presentation for Disaggregated Asian American, Native Hawaiian, and Pacific Islander Patients with Breast Cancer.
Ann Surg Oncol. 2025 Mar 24. doi: 10.1245/s10434-025-17133.
PubMed

CHEN Z, Zhang J, Chen W, Chen X, et al
ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients.
Ann Surg Oncol. 2025 Mar 24. doi: 10.1245/s10434-025-17243.
PubMed

LORENTZEN EH, Nguyen K, Chen YJ, King TA, et al
Downstream Effects of Omission of Axillary Surgery in Older Adults with Early-Stage HR+/HER2- Breast Cancer.
Ann Surg Oncol. 2025 Mar 21. doi: 10.1245/s10434-025-17196.
PubMed Abstract available

PITSINIS V, Benson J
Reply to: Letter to the Editor in Relation to 'Results of a Prospective Randomized Multicentre Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer:
Ann Surg Oncol. 2025 Mar 21. doi: 10.1245/s10434-025-17158.
PubMed

KARAMITROS G, Grant MP, Lamaris GA
Prophylactic Lymphovenous Bypass for Breast Cancer-Related Lymphedema: Research Challenges, Statistical Pitfalls, and Solutions.
Ann Surg Oncol. 2025 Mar 18. doi: 10.1245/s10434-025-17200.
PubMed

HAGERTY BL, Sato T, Wu R, Ishikawa T, et al
Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment.
Ann Surg Oncol. 2025 Mar 13. doi: 10.1245/s10434-025-17117.
PubMed Abstract available

OZCAN BB, Arjmandi FK, Polat DS, Xi Y, et al
ASO Visual Abstract: Factors Associated with Nodal Positivity Following Neoadjuvant Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI.
Ann Surg Oncol. 2025 Mar 13. doi: 10.1245/s10434-025-17137.
PubMed

CHEN Z, Zhang J, Chen W, Chen X, et al
Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients.
Ann Surg Oncol. 2025 Mar 11. doi: 10.1245/s10434-025-17110.
PubMed Abstract available

FLESHNER K, Quan ML
ASO Author Reflections: Uptake of Completion Axillary Lymph Node Dissection in Post-Neoadjuvant Chemotherapy Breast Cancer Patients.
Ann Surg Oncol. 2025 Mar 8. doi: 10.1245/s10434-025-17129.
PubMed

DOGAN B
ASO Author Reflections: Sentinel Lymph Node Biopsy in Node-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Considerations and Emerging Evidence.
Ann Surg Oncol. 2025 Mar 7. doi: 10.1245/s10434-025-17126.
PubMed

YOUNG J, Asaoka M, Ghasemi F, Chida K, et al
ASO Visual Abstract: The American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8th Edition is More Reflective of Cancer Biology Than the 7th Edition.
Ann Surg Oncol. 2025 Mar 6. doi: 10.1245/s10434-025-17065.
PubMed

PERRY LM, Sevilimedu V, Polidorio N, Abuhadra N, et al
Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.
Ann Surg Oncol. 2025 Mar 2. doi: 10.1245/s10434-025-17081.
PubMed Abstract available

GAU RY, Chou HH, Tsai HP, Shen SC, et al
Long-Term Follow-Up of Surgical Outcomes and Oncological Results of Nipple-Sparing Mastectomy with Immediate Reconstruction Through a Single Axillary Incision with Different Approach Methods.
Ann Surg Oncol. 2025;32:2092-2102.
PubMed Abstract available

HEELING E, Kramer GM, Volders JH, van Bommel ACM, et al
Increasing Rates but Persistent Variability of Immediate Breast Reconstruction: Real-Time Data from a Population-Based Study (2012-2022).
Ann Surg Oncol. 2025;32:1997-2006.
PubMed Abstract available

THAPLOO A, Kohli K, Wang S, Ho FDV, et al
Disparities in Stage at Presentation for Disaggregated Asian American, Native Hawaiian, and Pacific Islander Patients with Breast Cancer.
Ann Surg Oncol. 2025 Mar 1. doi: 10.1245/s10434-025-16974.
PubMed Abstract available

February 2025

BOROWSKY PA, Hernandez AE, Kesmodel SB, Goel N, et al
Genetic Ancestry and 21-Gene Oncotype DX Breast Cancer Recurrence Scores.
Ann Surg Oncol. 2025 Feb 27. doi: 10.1245/s10434-025-17012.
PubMed Abstract available

FLESHNER K, Xu Y, Isherwood S, Yang F, et al
Real-World Assessment of Locoregional Management of the Axilla in Node-Positive Breast Cancer After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2025 Feb 19. doi: 10.1245/s10434-025-17041.
PubMed Abstract available

CABIOGLU N, Karanlik H, Igci A, Muslumanoglu M, et al
ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03.
Ann Surg Oncol. 2025 Feb 18. doi: 10.1245/s10434-024-16746.
PubMed

KITAI T, Yamanaka K
Letter to the Editor in Relation to "Results of a Prospective Randomized Multicenter Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer: The INFLU
Ann Surg Oncol. 2025 Feb 14. doi: 10.1245/s10434-025-17016.
PubMed

OZCAN BB, Arjmandi FK, Polat DS, Xi Y, et al
Factors Associated with Nodal Positivity Following Neoadjuvant Systemic Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI.
Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16985.
PubMed Abstract available

BOUGHEY JC, Yu H, Switalla K, Velle L, et al
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.
Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16973.
PubMed Abstract available

REDDY KP, Fayanju OM
ASO Author Reflections: The Financial Impact of Delayed and Forgone Care Among Patients with Breast Cancer.
Ann Surg Oncol. 2025 Feb 11. doi: 10.1245/s10434-025-16969.
PubMed

YOUNG J, Asaoka M, Ghasemi F, Chida K, et al
The American Joint Committee on Cancer (AJCC) Breast Cancer Staging, Eighth Edition, is more Reflective of Cancer Biology than the Seventh Edition.
Ann Surg Oncol. 2025 Feb 7. doi: 10.1245/s10434-025-16889.
PubMed Abstract available

ZHANG M, Yuan L, Cui M, Chen J, et al
ASO Author Reflections: Personal Insights and Reflections on the Burden of Breast Cancer Among Adolescents and Young Adults.
Ann Surg Oncol. 2025 Feb 6. doi: 10.1245/s10434-024-16858.
PubMed

LAWS A, Leonard S, Vincuilla J, Parker T, et al
ASO Visual Abstract: Risk of Surgical Overtreatment in cN1 Breast Cancer Patients Who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
Ann Surg Oncol. 2025 Feb 3. doi: 10.1245/s10434-025-16952.
PubMed

COLEMAN-BELIN JC, Rubin J, Boe LA, Diwan R, et al
Protective Factors Associated with Normal Lymphatic Function After Axillary Lymph Node Dissection for Breast Cancer Treatment.
Ann Surg Oncol. 2025 Feb 3. doi: 10.1245/s10434-025-16918.
PubMed Abstract available

SINGH P, Agnese DM, Amin M, Barrio AV, et al
Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks.
Ann Surg Oncol. 2025;32:899-911.
PubMed Abstract available

KHAN MMM, Khalil M, Stecko H, Pawlik TM, et al
Disparities in Next-Generation Genetic Sequencing Among Individuals with Cancer.
Ann Surg Oncol. 2025;32:650-652.
PubMed Abstract available

WINER L, Ruth KJ, Bleicher RJ, Nagarathinam R, et al
Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2-Overexpressing Breast Cancers.
Ann Surg Oncol. 2025;32:931-943.
PubMed Abstract available

LIU LL, Lin YK, Xiang ZL
The Value of Primary Tumor Resection in Patients with Liver Metastases: A 10-Year Outcome.
Ann Surg Oncol. 2025;32:1083-1092.
PubMed Abstract available

ESPARHAM A, Shoar S, Whittington J, Shafaee Z, et al
National Trends and In-Hospital Outcomes for Immediate Implant-Based Versus Autologous-Based Breast Reconstruction: A Propensity Score-Matched Analysis.
Ann Surg Oncol. 2025;32:985-992.
PubMed Abstract available

January 2025

SCHUMACHER JR, Tucholka JL, Breuer CR, McKinney GH, et al
Ongoing Symptoms and Concerns Experienced by Low-Risk Breast Cancer Survivors Following Active Treatment.
Ann Surg Oncol. 2025 Jan 29. doi: 10.1245/s10434-025-16959.
PubMed Abstract available

NTOWE KW, Lee MS, Yi VN, Kaplan SJ, et al
ASO Visual Abstract: Short-Term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at High Risk for Breast Cancer: A Systematic Review.
Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16902.
PubMed

REDDY KP, Jarrell K, Berkowitz C, Hulse S, et al
ASO Visual Abstract: Association Between Delayed/Forgone Medical Care and Resource Utilization Among Women with Breast Cancer in the United States.
Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-024-16776.
PubMed

CHRISTENHUSZ A, Mirzaei N, Karakatsanis A, Eriksson S, et al
ASO Visual Abstract: Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-Analysis of Tracer Uptake.
Ann Surg Oncol. 2025 Jan 22. doi: 10.1245/s10434-024-16780.
PubMed

YI JP, Yoon CI, Lim SH, Choi H, et al
ASO Visual Abstract: Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study.
Ann Surg Oncol. 2025 Jan 16. doi: 10.1245/s10434-025-16870.
PubMed

VAN DEN BRUELE AB, Williams A, Weiss A
Commentary and Updates on the Management of Male Breast Cancer.
Ann Surg Oncol. 2025 Jan 13. doi: 10.1245/s10434-024-16756.
PubMed

CHO MJ, Chratian S, Skoracki R
ASO Author Reflections: Breast Cancer-Related Lymphedema Prevention: The Impact of Prophylactic Lymphovenous Bypass.
Ann Surg Oncol. 2025 Jan 12. doi: 10.1245/s10434-024-16824.
PubMed

FEFFERMAN ML, Thompson DM, Wilke LG, Hwang S, et al
ASO Visual Abstract: Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data.
Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16777.
PubMed

DARIYA S, Agarwal G
Letter to the Editor: Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.
Ann Surg Oncol. 2025 Jan 7. doi: 10.1245/s10434-024-16839.
PubMed

NTOWE KW, Lee MS, Yi VN, Kaplan SJ, et al
Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.
Ann Surg Oncol. 2025 Jan 4. doi: 10.1245/s10434-024-16805.
PubMed Abstract available

CHO MJ, Senger JL, Park KU, Hansotia K, et al
ASO Visual Abstract: Preventing Breast Cancer-Related Lymphedema-A Comprehensive Analysis of a 9-Year Single-Center Experience of Prophylactic Lymphovenous Bypass.
Ann Surg Oncol. 2025 Jan 4. doi: 10.1245/s10434-024-16784.
PubMed

GIANNAKOU A, Kantor O, Park KU, Waks AG, et al
ASO Visual Abstract: Real-World Implications of the SOUND Trial.
Ann Surg Oncol. 2025;32:121-122.
PubMed Abstract available

KIM M, Amakiri UO, Wong F, Barnett J, et al
Race and Ethnicity Impacts Patient-Reported Outcomes in Implant-Based Breast Reconstruction.
Ann Surg Oncol. 2025;32:551-561.
PubMed Abstract available

KHUBCHANDANI JA, Suttiratana SC, Washington R, White-Bracey D, et al
Living Flat: Stories from Women of Color After Mastectomy.
Ann Surg Oncol. 2025;32:104-114.
PubMed Abstract available

WANG X, Jackson J, Weed C, Boyle MK, et al
Staged Nipple Delay Procedure Expands Candidacy for Nipple-Sparing Mastectomy.
Ann Surg Oncol. 2025;32:98-103.
PubMed Abstract available

MATAR-UJVARY R, Sevilimedu V, Morrow M
Are Clinically Node-Negative Patients with a Positive Preoperative Axillary Lymph Node Biopsy Appropriate Candidates for Sentinel Lymph Node Biopsy?
Ann Surg Oncol. 2025;32:92-97.
PubMed Abstract available

December 2024

YANG Z, Wu T, Chen P, Li L, et al
Recurrence Patterns and Long-Term Results After Curative Surgery for Patients With Breast Cancer.
Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16726.
PubMed Abstract available

SELFRIDGE JM, Schrank Z, Agala CB, Ollila DW, et al
ASO Visual Abstract: Outcomes and Trends in Axillary Management of Patients with Stage cN3b Breast Cancer.
Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16783.
PubMed

CHO MJ, Senger JL, Park KU, Hansotia K, et al
Preventing Breast Cancer-Related Lymphedema: A Comprehensive Analysis of a 9-Year Single-Center Experience of Prophylactic Lymphovenous Bypass.
Ann Surg Oncol. 2024 Dec 23. doi: 10.1245/s10434-024-16640.
PubMed Abstract available

CHRISTENHUSZ A, Mirzaei N, Warnberg F, Alic L, et al
ASO Author Reflections: Redefining Precision-Insights into Magnetic Sentinel Lymph Node Biopsy for Early Breast Cancer.
Ann Surg Oncol. 2024 Dec 21. doi: 10.1245/s10434-024-16725.
PubMed

KANG YJ, Yi JP, Yoon CI
ASO Author Reflections: Hidden Impact of COVID-19 on Breast Cancer Outcomes: Lessons From South Korea.
Ann Surg Oncol. 2024 Dec 21. doi: 10.1245/s10434-024-16721.
PubMed

REDDY KP, Jarrell K, Berkowitz C, Hulse S, et al
Association Between Delayed/Forgone Medical Care and Resource Utilization Among Women with Breast Cancer in the United States.
Ann Surg Oncol. 2024 Dec 18. doi: 10.1245/s10434-024-16586.
PubMed Abstract available

SCHRANK Z, Selfridge JM
ASO Author Reflections: Can Axillary Lymph Node Dissection be Safely Avoided for Some Stage cN3b Breast Cancer Patients?
Ann Surg Oncol. 2024 Dec 18. doi: 10.1245/s10434-024-16724.
PubMed

TAHTASAKAL R, Hamurcu Z, Oz AB, Balli M, et al
miR-484 as an "OncomiR" in Breast Cancer Promotes Tumorigenesis by Suppressing Apoptosis Genes.
Ann Surg Oncol. 2024 Dec 18. doi: 10.1245/s10434-024-16656.
PubMed Abstract available

CHRISTENHUSZ A, Mirzaei N, Karakatsanis A, Eriksson S, et al
Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-analysis of Tracer Uptake.
Ann Surg Oncol. 2024 Dec 17. doi: 10.1245/s10434-024-16626.
PubMed Abstract available

SELFRIDGE JM, Schrank Z, Agala CB, Ollila DW, et al
Outcomes and Trends in Axillary Management of Stage cN3b Breast Cancer Patients.
Ann Surg Oncol. 2024 Dec 14. doi: 10.1245/s10434-024-16630.
PubMed Abstract available

ZHANG M, Yuan L, Cui M, Chen J, et al
Analysis the Burden of Breast Cancer Among Adolescents and Young Adults Using the Global Burden of Disease 2021.
Ann Surg Oncol. 2024 Dec 12. doi: 10.1245/s10434-024-16648.
PubMed Abstract available

FEFFERMAN ML, Thompson DM, Wilke LG, Hwang S, et al
Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data.
Ann Surg Oncol. 2024 Dec 10. doi: 10.1245/s10434-024-16594.
PubMed Abstract available

PANG J, Ding N, Liu X, He X, et al
ASO Author Reflections: Reflections on the Role of the Systemic Immune-Inflammation Index in Prognostic Assessment in HER2-Positive Metastatic Breast Cancer.
Ann Surg Oncol. 2024 Dec 10. doi: 10.1245/s10434-024-16664.
PubMed

REH N, Caston NE, Williams CP, Dwarampudi SR, et al
Therapeutic Clinical Trial Eligibility and Enrollment among Women with Breast Cancer: Implications for Understanding Trial Disparities.
Ann Surg Oncol. 2024 Dec 9. doi: 10.1245/s10434-024-16607.
PubMed Abstract available

CABIOGLU N, Karanlik H, Igci A, Muslumanoglu M, et al
ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Ir
Ann Surg Oncol. 2024 Dec 9. doi: 10.1245/s10434-024-16651.
PubMed Abstract available

SHIM V, Karlea A, Brenman LM, Gul J, et al
ASO Visual Abstract: Impact of Mainstream Germline Genetic Testing with Expanded Eligibility for Early Stage Breast Cancer Patients in a Large Integrated Health System.
Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16559.
PubMed

YI JP, Yoon CI, Lim SH, Choi H, et al
Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study.
Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16645.
PubMed Abstract available

LAWS A, Leonard S, Vincuilla J, Parker T, et al
Risk of Surgical Overtreatment in cN1 Breast Cancer Patients who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16625.
PubMed Abstract available

WINER LK, Williams AD
ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer.
Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16606.
PubMed

CABIOGLU N, Karanlik H, Igci A, Muslumanoglu M, et al
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03.
Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16472.
PubMed Abstract available

GIANNAKOU A, Kantor O, Park KU, Waks AG, et al
Real-World Implications of the SOUND Trial.
Ann Surg Oncol. 2024;31:8776-8785.
PubMed Abstract available

WOESTE MR, Jacob K, Shindorf M, Gaskins JT, et al
Identifying Factors Predicting Margin Status After Mastectomy.
Ann Surg Oncol. 2024;31:8882-8890.
PubMed Abstract available

ECKERT KM, Hoskin TL, Olson CA, Goetz MP, et al
In-Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence-Free Survival.
Ann Surg Oncol. 2024;31:8856-8865.
PubMed Abstract available

DISKIN B, Sevilimedu V, Morrow M, Van Zee K, et al
Management of Ipsilateral Breast Tumor Recurrence Following Breast Conservation Surgery for Ductal Carcinoma In Situ: A Data-Poor Zone.
Ann Surg Oncol. 2024;31:8843-8847.
PubMed Abstract available

DEY P, Kc M, Proussaloglou EM, Khubchandani JA, et al
Incidence of Pathologic Nodal Disease in Clinically Node-Negative, Microinvasive or T1a Breast Cancers.
Ann Surg Oncol. 2024;31:8821-8828.
PubMed Abstract available

LIMBERG JN, Jones T, Thomas SM, Ntowe KW, et al
Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024;31:8813-8820.
PubMed Abstract available

November 2024

SAMPLE JW, Hoskin TL, Johnson JE, Mrdutt MM, et al
ASO Visual Abstract: Early Compliance with Commission on Cancer Operative Standards for Breast Cancer Surgery.
Ann Surg Oncol. 2024 Nov 26. doi: 10.1245/s10434-024-16583.
PubMed

HUSTON-PATERSON HH, Mora V, Karlan BY, Teshome M, et al
Medicaid Coverage of NCCN- and ASCO/SSO-Guideline-Concordant BRCA Germline Testing for Patients with Breast Cancer: Opportunity to Embrace Rapid Advancements in Precision Medicine.
Ann Surg Oncol. 2024 Nov 23. doi: 10.1245/s10434-024-16306.
PubMed Abstract available

PANG J, Ding N, Liu X, He X, et al
Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials.
Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16454.
PubMed Abstract available

SO A, Yi M, Simons JM, Kuerer HM, et al
ASO Visual Abstract: Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16506.
PubMed

MUPPIDI N, Adesoye T, Yi M, Sun SX, et al
ASO Visual Abstract: Clinical Outcomes for Early-Stage Node-Negative HER2-Positive Breast Cancer Patients Receiving Upfront Surgery or Neoadjuvant Systemic Therapy.
Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16213.
PubMed

HU J, Deng X, Li L, Liu H, et al
ASO Visual Abstract: The Predictive Factors of Combined Implant Application for Breast Cancer Patients Receiving Immediate Breast Reconstruction with a Pedicled Omental Flap.
Ann Surg Oncol. 2024 Nov 16. doi: 10.1245/s10434-024-16500.
PubMed

SO A, Hunt KK
ASO Author Reflections: De-escalating Axillary Surgery in Patients with Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024 Nov 13. doi: 10.1245/s10434-024-16461.
PubMed

SAMPLE JW, Hoskin TL, Johnson JE, Mrdutt MM, et al
Early Compliance with Commission on Cancer Operative Standards for Breast Cancer Surgery.
Ann Surg Oncol. 2024 Nov 10. doi: 10.1245/s10434-024-16477.
PubMed Abstract available

VASIGH M, Mohamed A, Jacobs L, Lange J, et al
ASO Visual Abstract: The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer.
Ann Surg Oncol. 2024 Nov 5. doi: 10.1245/s10434-024-16404.
PubMed

MCCAFFREY RL, James AJ, Torres-Guzman RA, Addae JK, et al
Incidence of High Risk and Malignant Pathological Findings in Transgender and Gender Diverse Individuals Undergoing Gender-Affirming Mastectomy.
Ann Surg Oncol. 2024;31:8086-8092.
PubMed Abstract available

GOTTIPATI S, Goldbach M, Tchou J
ASO Author Reflections: Rationale to Routinely Retest ER, PR and HER-2/neu Receptor Status in Residual Disease After Neoadjvuant Chemotherapy.
Ann Surg Oncol. 2024;31:8108-8109.
PubMed

HO IW, Chichura A, Pederson HJ, Xavier BA, et al
Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients.
Ann Surg Oncol. 2024;31:8372-8382.
PubMed Abstract available

HANEY V, Lee SM, Goldman J, Akiska YM, et al
Evaluating the Effect of MarginProbe((R)) Use on Re-excisions After Partial Mastectomy: A Single-Institution Analysis.
Ann Surg Oncol. 2024;31:8068-8075.
PubMed Abstract available

DEL CALVO H, Wu Y, Lin HY, Nassif EF, et al
Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast.
Ann Surg Oncol. 2024;31:8048-8056.
PubMed Abstract available

KIM M, Tadros AB, Boe LA, Vingan P, et al
Breast-Conserving Therapy Versus Postmastectomy Breast Reconstruction: Propensity Score-Matched Analysis.
Ann Surg Oncol. 2024;31:8030-8039.
PubMed Abstract available

AMAKIRI UO, Tadros AB, Kim M, Boe LA, et al
ASO Author Reflections: Propensity Score-Matched Patient-Reported Outcomes After Breast-Conserving Therapy and Postmastectomy Breast Reconstruction.
Ann Surg Oncol. 2024;31:8104-8105.
PubMed

October 2024

MOORE AM, Caudle AS, Sun SX, Yi M, et al
ASO Visual Abstract: Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer.
Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16397.
PubMed

SO A, Yi M, Simons JM, Kuerer HM, et al
Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16382.
PubMed Abstract available

BAYLEY EM, Liu HY, Bonetti MA, Egro FM, et al
ChatGPT as Valuable Patient Education Resource in Breast Cancer Care.
Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16369.
PubMed

CONNORS C, Valente SA, ElSherif A, Escobar P, et al
Real-World Outcomes with the KEYNOTE-522 Regimen in Early-Stage Triple-Negative Breast Cancer.
Ann Surg Oncol. 2024 Oct 22. doi: 10.1245/s10434-024-16390.
PubMed Abstract available

MOORE AM, Caudle AS, Sun SX, Yi M, et al
Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer.
Ann Surg Oncol. 2024 Oct 17. doi: 10.1245/s10434-024-16341.
PubMed Abstract available

ESPARHAM A, Shoar S, Whittington J, Shafaee Z, et al
ASO Author Reflections: Immediate Implant-Based Versus Autologous-Based Breast Reconstruction After Mastectomy in Patients with Breast Cancer.
Ann Surg Oncol. 2024 Oct 12. doi: 10.1245/s10434-024-16374.
PubMed

KIM LS, Moore MS, Schneider E, Canner J, et al
ASO Visual Abstract: National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer.
Ann Surg Oncol. 2024 Oct 2. doi: 10.1245/s10434-024-16259.
PubMed

KIM M, Matros E, Boe LA, Stern CS, et al
Predicting Postoperative Satisfaction with Breasts: How Important is the Preoperative BREAST-Q Score?
Ann Surg Oncol. 2024;31:6602-6610.
PubMed Abstract available

LORENTZEN EH, Chen YJ, Jin G, King TA, et al
Potential Overtreatment of DCIS in Patients with Limited Life Expectancy.
Ann Surg Oncol. 2024;31:6812-6819.
PubMed Abstract available

JONES VM, Nelson JA, Sevilimedu V, Le T, et al
Impact of Mastectomy Flap Necrosis on Patient-Reported Quality-of-Life Measures After Nipple-Sparing Mastectomy: A Preliminary Analysis.
Ann Surg Oncol. 2024;31:6795-6803.
PubMed Abstract available

DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
Correction: Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
Ann Surg Oncol. 2024 Oct 1. doi: 10.1245/s10434-024-16315.
PubMed

GASS J, Teshome M, Blair SL
25nd Annual Meeting of the American Society of Breast Surgeons: Our Silver Jubilee.
Ann Surg Oncol. 2024;31:7245-7246.
PubMed

JACKSON KM, Grumley JG
ASO Author Reflections: Employment of Oncoplastic Breast Surgery for Management of Large, Multifocal, or Multicentric Breast Cancers: Another Tool in the Toolbox.
Ann Surg Oncol. 2024;31:7594-7595.
PubMed

MILLEN JC, Grumley JG
ASO Author Reflections: Cost Comparison of Extreme Oncoplastic Breast-Conserving Surgery and Mastectomy with Reconstruction.
Ann Surg Oncol. 2024;31:7471.
PubMed

ELMORE LR, Bayley EM, Clark BZ, McAuliffe PF, et al
Is the Number or Proximity of Margins Less than 2 mm Associated with an Increased Mastectomy Rate in Patients Attempting Breast Conservation Therapy for Ductal Carcinoma In Situ?
Ann Surg Oncol. 2024;31:7609-7618.
PubMed Abstract available

HUA T, Wright GP, Thompson JL
ASO Author Reflections: The Utility of Clinical Breast Examinations in a High-Risk Patient Population.
Ann Surg Oncol. 2024;31:7532-7533.
PubMed

JACKSON KM, Millen JC, Handy N, Orozco JIJ, et al
Breast Conservation Project: Clinical Outcomes of Extreme Oncoplastic Breast-Conserving Therapy Versus Mastectomy for Large and Multiple Lesions.
Ann Surg Oncol. 2024;31:7582-7593.
PubMed Abstract available

AUBREY JM, Levine A, Movassaghi A, Liefeld HR, et al
2021 CMS Evaluation and Management Guideline Changes Reduce Note Length in Outpatient Breast Surgery Documentation.
Ann Surg Oncol. 2024;31:7535-7537.
PubMed

WEISS A, Mitchell M, O'Sullivan CC, Boughey JC, et al
ASO Author Reflections: Extreme Early Adoption-The Omission of Axillary Lymph Node Dissection is Being Adopted into Practice Before Clinical Trial Data are Available: Where Might this Lead?
Ann Surg Oncol. 2024;31:7372-7374.
PubMed

CLELLAND EN, Mukhtar RA
ASO Author Reflections: Detecting Local Recurrence After Primary Treatment for Invasive Lobular Carcinoma of the Breast.
Ann Surg Oncol. 2024;31:7323-7324.
PubMed

GAO TP, HoSang KM, Bleicher RJ, Kuo LE, et al
Evolving Economics: The Erosion of Medicare Reimbursement in Breast Surgery (2003-2023).
Ann Surg Oncol. 2024;31:7303-7311.
PubMed Abstract available

VEMURU S, Helmkamp L, Adams M, Colborn K, et al
Longitudinal Trends in Patient-Reported Outcomes in the First Year After Lumpectomy Versus Mastectomy.
Ann Surg Oncol. 2024;31:7597-7606.
PubMed Abstract available

DALTON EC, Williams AD
ASO Author Reflections: Put the Scalpel Down-Axillary Surgery is not Indicated for Patients >/= 70 Years Undergoing Mastectomy for DCIS.
Ann Surg Oncol. 2024;31:7508-7509.
PubMed

CARDARELLI CL, Dalton EC, Chang C, Williams AD, et al
Should Palpable Nodes Be Exclusionary in Patients Who Are Otherwise Candidates for ACOSOG Z0011-Type Trials?
Ann Surg Oncol. 2024;31:7445-7458.
PubMed Abstract available

HOSSINO D, Silverstein MJ, Savalia N, Jayich M, et al
Extreme Oncoplasty: Oncologically Safe When Compared with Mastectomy.
Ann Surg Oncol. 2024;31:7284-7288.
PubMed Abstract available

MILLEN JC, Sibia U, Jackson K, Stern SL, et al
Comparing Costs: Does Extreme Oncoplastic Breast-Conserving Surgery Confer a Cost Benefit When Compared with Mastectomy and Reconstruction?
Ann Surg Oncol. 2024;31:7463-7470.
PubMed Abstract available

PILTIN MA, Norwood P, Ladores V, Mukhtar RA, et al
Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
Ann Surg Oncol. 2024;31:7420-7428.
PubMed Abstract available

DALTON EC, Chang C, Cardarelli C, Bleicher RJ, et al
Nodal Surgery for Patients >/= 70 Undergoing Mastectomy for DCIS? Choose Wisely.
Ann Surg Oncol. 2024;31:7498-7507.
PubMed Abstract available

WEISS A, Colugnati F, Mitchell M, Li Y, et al
Contemporary Axillary Surgical Management in Patients with Pathologically Node Positive Disease After Neoadjuvant Chemotherapy: A Survey of Members of the American Society of Breast Surgeons.
Ann Surg Oncol. 2024;31:7362-7371.
PubMed Abstract available

JAKUB JW, Boughey JC, Hieken TJ, Piltin M, et al
Lymphedema Rates Following Axillary Lymph Node Dissection With and Without Immediate Lymphatic Reconstruction: A Prospective Trial.
Ann Surg Oncol. 2024;31:7349-7359.
PubMed Abstract available

CLELLAND EN, Quirarte A, Rothschild HT, Kaur M, et al
Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast: Method of Local Recurrence Detection After Breast-Conserving Surgery.
Ann Surg Oncol. 2024;31:7315-7322.
PubMed Abstract available

FALADE I, Mukhtar RA
ASO Author Reflections: The Oncologic Safety of Immediate Oncoplastic Approaches in Invasive Lobular Carcinoma.
Ann Surg Oncol. 2024;31:7418-7419.
PubMed

FALADE I, Switalla K, Quirarte A, Baxter M, et al
Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma.
Ann Surg Oncol. 2024;31:7409-7417.
PubMed Abstract available

September 2024

SHIM V, Karlea A, Habel L
ASO Author Reflections: Mainstream Genetic Testing Makes It Feasible for a Large Integrated System to Expand the Testing Eligibility in Breast Cancer.
Ann Surg Oncol. 2024 Sep 28. doi: 10.1245/s10434-024-16311.
PubMed

VASIGH M, Mohamed A, Jacobs L, Lange J, et al
The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer.
Ann Surg Oncol. 2024 Sep 27. doi: 10.1245/s10434-024-16243.
PubMed Abstract available

KIM LS, Moore MS, Schneider E, Canner J, et al
National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer.
Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16107.
PubMed Abstract available

DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
ASO Visual Abstract: Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16070.
PubMed

MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
ASO Visual Abstract: Financial Toxicity Among Women with Breast Cancer Varies by Age and Race.
Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16091.
PubMed

SAUCKE MC, Jacobson N, McKinney G, Neuman HB, et al
Role of the Surgeon in De-Escalating Emotion During a Breast Cancer Surgery Consultation: A Qualitative Study of Patients' Experiences in Alliance A231701CD.
Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16156.
PubMed Abstract available

PITSINIS V, Kanitkar R, Vinci A, Choong WL, et al
ASO Author Reflections: ICG Fluorescent-Guided Surgery for Sentinel Lymph Node Biopsy Used as a Single Tracer Shown Sensitivity, Safety, and Efficacy in Early Breast Cancer Surgery.
Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16266.
PubMed

FREEMAN JQ, Huo D, Howard FM
ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine Era.
Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16265.
PubMed Abstract available

RECORD SM, Thomas SM, Dalton J, van den Bruele AB, et al
ASO Visual Abstract: Triple-Negative Breast Cancer in Older Patients: Does SLNB Guide Therapy?
Ann Surg Oncol. 2024 Sep 21. doi: 10.1245/s10434-024-16249.
PubMed

FU MR, Liu B, Qiu JM, Sun Y, et al
ASO Visual Abstract: The Effects of Daily-Living Risks on Breast Cancer-Related Lymphedema.
Ann Surg Oncol. 2024 Sep 19. doi: 10.1245/s10434-024-16231.
PubMed

SHIM V, Karlea A, Brenman LM, Gul J, et al
Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.
Ann Surg Oncol. 2024 Sep 18. doi: 10.1245/s10434-024-16223.
PubMed Abstract available

PARRISH KM, Thomas SM, Cartwright SB, van den Bruele AB, et al
ASO Visual Abstract: Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer-A National Cancer Database Study.
Ann Surg Oncol. 2024 Sep 18. doi: 10.1245/s10434-024-16206.
PubMed

AN SJ, Thai CHNC, Ismail S, Agala CB, et al
ASO Visual Abstract: Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution.
Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16210.
PubMed

FINE RE, Gilmore RC, Tomkovich KR, Dietz JR, et al
Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.
Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16181.
PubMed Abstract available

PITSINIS V, Kanitkar R, Vinci A, Choong WL, et al
Results of a Prospective Randomized Multicenter Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer: The INFLUENCE Trial.
Ann Surg Oncol. 2024 Sep 12. doi: 10.1245/s10434-024-16176.
PubMed Abstract available

DALTON JC, Record SM, Plichta JK
ASO Author Reflections: Investigating the Role of Sentinel Lymph Node Biopsy in Older Patients with Triple-Negative Breast Cancer.
Ann Surg Oncol. 2024 Sep 12. doi: 10.1245/s10434-024-16236.
PubMed

FREEMAN JQ, Shubeck SP, Chen N, Yarlagadda SR, et al
Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer.
Ann Surg Oncol. 2024 Sep 9. doi: 10.1245/s10434-024-16160.
PubMed Abstract available

MUPPIDI N, Adesoye T, Hunt KK, Teshome M, et al
ASO Author Reflections: Evolving Multidisciplinary Decision Making for Early-Stage, HER2-Positive Breast Cancer.
Ann Surg Oncol. 2024 Sep 9. doi: 10.1245/s10434-024-16190.
PubMed

PARRISH K, Chiba A
ASO Author Reflections: Not All pCRs are Created Equal, the Challenge of Inflammatory Breast Cancer.
Ann Surg Oncol. 2024 Sep 7. doi: 10.1245/s10434-024-16129.
PubMed

SHAH C, Whitworth P, Vicini FA, Narod S, et al
ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT((R)) PREDICT Study.
Ann Surg Oncol. 2024;31:5959-5960.
PubMed

SHAH C, Whitworth P, Vicini FA, Narod S, et al
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT((R)) PREDICT Study.
Ann Surg Oncol. 2024;31:5919-5928.
PubMed Abstract available

RAHURKAR S, Jonnalagadda P, Stover D, Andersen B, et al
Identifying and Treating Those at Risk: Disparities in Rapid Relapse Among TNBC Patients in the National Cancer Database.
Ann Surg Oncol. 2024;31:5896-5910.
PubMed Abstract available

PARK KU, Padamsee TJ, Birken SA, Lee S, et al
Factors Influencing Implementation of the Commission on Cancer's Breast Synoptic Operative Report (Alliance A20_Pilot9).
Ann Surg Oncol. 2024;31:5888-5895.
PubMed Abstract available

SETO Y, Ishitobi M, Shien T, Oshiro C, et al
ASO Visual Abstract: Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.
Ann Surg Oncol. 2024;31:5957-5958.
PubMed

August 2024

CORTINA CS, Purdy A, Brazauskas R, Stachowiak SM, et al
ASO Visual Abstract: The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals-A Pilot Single-Arm Educational Intervention Trial.
Ann Surg Oncol. 2024 Aug 30. doi: 10.1245/s10434-024-15905.
PubMed

FERRUCCI M, Passeri D, Milardi F, Francavilla A, et al
ASO Visual Abstract: Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged >/= 90 Years: A Large Retrospective Cohort Study.
Ann Surg Oncol. 2024 Aug 29. doi: 10.1245/s10434-024-16086.
PubMed

RECORD SM, Thomas SM, Dalton J, van den Bruele AB, et al
Triple-Negative Breast Cancer in Older Patients: Does SLNB Guide Therapy?
Ann Surg Oncol. 2024 Aug 28. doi: 10.1245/s10434-024-16106.
PubMed Abstract available

MUPPIDI N, Adesoye T, Yi M, Sun SX, et al
Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy.
Ann Surg Oncol. 2024 Aug 27. doi: 10.1245/s10434-024-16087.
PubMed Abstract available

FU MR, Liu B, Qiu JM, Sun Y, et al
ASO Author Reflections: Infection and Skin Trauma Incrementally Increase the Risk of Breast Cancer-Related Lymphedema.
Ann Surg Oncol. 2024 Aug 25. doi: 10.1245/s10434-024-16078.
PubMed

MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
ASO Author Reflections: Young Adults and Racial Minorities May Be at High Risk for Financial Toxicity After Breast Cancer Treatment.
Ann Surg Oncol. 2024 Aug 22. doi: 10.1245/s10434-024-16050.
PubMed

LIMBERG JN, Thomas SM, Dalton JC, Ntowe KW, et al
ASO Visual Abstract: Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia.
Ann Surg Oncol. 2024 Aug 19. doi: 10.1245/s10434-024-15963.
PubMed

TCHOU J, Gottipati S, Goldbach M, Baxter M, et al
ASO Visual Abstract: Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and is Common in Patients with HER2+ Breast Cancer.
Ann Surg Oncol. 2024 Aug 19. doi: 10.1245/s10434-024-16090.
PubMed

PARRISH KM, Thomas SM, Cartwright SB, van den Bruele AB, et al
Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study.
Ann Surg Oncol. 2024 Aug 19. doi: 10.1245/s10434-024-16026.
PubMed Abstract available

AN SJ, Thai CHNC, Ismail S, Agala CB, et al
Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution.
Ann Surg Oncol. 2024 Aug 17. doi: 10.1245/s10434-024-16059.
PubMed Abstract available

MACCALLUM C, Elder K, Nickson C, Ruecker K, et al
ASO Visual Abstract: Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer.
Ann Surg Oncol. 2024 Aug 17. doi: 10.1245/s10434-024-15996.
PubMed

HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
ASO Visual Abstract: Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
Ann Surg Oncol. 2024 Aug 16. doi: 10.1245/s10434-024-15990.
PubMed

SWITALLA KM, Boughey JC, Dimitroff K, Yau C, et al
ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
Ann Surg Oncol. 2024 Aug 13. doi: 10.1245/s10434-024-15965.
PubMed

CHENG O, Fiser C, Paysour J, Aluwalia R, et al
Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
Ann Surg Oncol. 2024 Aug 13. doi: 10.1245/s10434-024-15789.
PubMed Abstract available

KHORFAN R, Vora HP, Namm JP, Solomon NL, et al
Expanded Indications for Neoadjuvant Endocrine Therapy in Early-Stage Breast Cancer During the COVID-19 Pandemic.
Ann Surg Oncol. 2024 Aug 12. doi: 10.1245/s10434-024-15787.
PubMed Abstract available

GLENCER AC, Wanis KN, Brown S, Lucci A, et al
ASO Visual Abstract: Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership-Consensus and Opportunities.
Ann Surg Oncol. 2024 Aug 10. doi: 10.1245/s10434-024-15910.
PubMed

LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients after Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024 Aug 9. doi: 10.1245/s10434-024-15796.
PubMed Abstract available

TCHOU J, Gottipati S, Goldbach M, Baxter M, et al
Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.
Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15889.
PubMed Abstract available

DI LENA E, Iny E, Wong SM, Bassel M, et al
ASO Visual Abstract: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.
Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15961.
PubMed

MATTAR A, Antonini M, Amorim A, Mateus EF, et al
ASO Visual Abstract: PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer.
Ann Surg Oncol. 2024 Aug 6. doi: 10.1245/s10434-024-15971.
PubMed

WANIS KN, Goetz L, So A, Glencer AC, et al
ASO Visual Abstract: The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast
Ann Surg Oncol. 2024 Aug 6. doi: 10.1245/s10434-024-15913.
PubMed

HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
Correction: Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
Ann Surg Oncol. 2024 Aug 5. doi: 10.1245/s10434-024-16009.
PubMed

FERRUCCI M, Passeri D, Milardi F, Francavilla A, et al
Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged >/=90 Years: A Large Retrospective Cohort Study.
Ann Surg Oncol. 2024 Aug 4. doi: 10.1245/s10434-024-15790.
PubMed Abstract available

KHORFAN R, Vora HP, Namm JP, Solomon NL, et al
ASO Visual Abstract: Expanded Indications for Neoadjuvant Endocrine Therapy in Early Stage Breast Cancer During the COVID-19 Pandemic.
Ann Surg Oncol. 2024 Aug 4. doi: 10.1245/s10434-024-15921.
PubMed

DALTON JC, Crowell KA, Ntowe KW, van den Bruele AB, et al
ASO Visual Abstract: Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer.
Ann Surg Oncol. 2024 Aug 2. doi: 10.1245/s10434-024-15972.
PubMed

FALADE I, Switalla K, Quirarte A, Baxter M, et al
ASO Visual Abstract: Oncologic Safety of Immediate Oncoplastic Surgery Compared to Standard Breast Conserving Surgery for Patients with Invasive Lobular Carcinoma.
Ann Surg Oncol. 2024;31:5004-5005.
PubMed

DALY AE, Anderman KJ, Smith BL
ASO Author Reflections: Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.
Ann Surg Oncol. 2024;31:5211-5212.
PubMed

SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
ASO Visual Abstract: Positive Nipple Margins in Nipple Sparing Mastectomy-Management of Nipples Containing Cancer or Atypia.
Ann Surg Oncol. 2024;31:5230.
PubMed

HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
ASO Visual Abstract: "Peace of Mind" After Mastectomy: A Scoping Review.
Ann Surg Oncol. 2024;31:5213-5214.
PubMed

WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
ASO Visual Abstract: Simultaneous Co-surgeon Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstructions-Feasibility and Clinical Outcomes.
Ann Surg Oncol. 2024;31:5419-5420.
PubMed

BEST CS, Kung TA
ASO Author Reflections: Improving Patient Access to Autologous Breast Reconstruction.
Ann Surg Oncol. 2024;31:5417-5418.
PubMed

HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
"Peace of Mind" After Mastectomy: A Scoping Review.
Ann Surg Oncol. 2024;31:5168-5179.
PubMed Abstract available

SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.
Ann Surg Oncol. 2024;31:5148-5156.
PubMed Abstract available

WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
Simultaneous Co-surgeon Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstructions: Feasibility and Clinical Outcomes.
Ann Surg Oncol. 2024;31:5409-5416.
PubMed Abstract available

FU MR, Liu B, Qiu JM, Sun Y, et al
The Effects of Daily-Living Risks on Breast Cancer-Related Lymphedema.
Ann Surg Oncol. 2024 Aug 1. doi: 10.1245/s10434-024-15946.
PubMed Abstract available

NTOWE KW, Thomas SM, Dalton JC, Olunuga E, et al
ASO Visual Abstract: Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.
Ann Surg Oncol. 2024 Aug 1. doi: 10.1245/s10434-024-15922.
PubMed

MOORE AM, Caudle AS, Sun SX, Yi M, et al
ASO Visual Abstract: Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes on Targeted Axillary Dissection.
Ann Surg Oncol. 2024 Aug 1. doi: 10.1245/s10434-024-15966.
PubMed

July 2024

MACCALLUM C, Elder K, Nickson C, Ruecker K, et al
ASO Author Reflections: Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer.
Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15953.
PubMed

GAO T, HoSang K, Bleicher R, Kuo L, et al
ASO Author Reflections: The Looming Challenge of Declining Reimbursements in Breast Cancer Care.
Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15838.
PubMed

DALTON JC, Plichta JK
ASO Author Reflections: Personalized Surgical Considerations in Older Women with HER2-Positive Breast Cancer.
Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15930.
PubMed

SHAH C, Boyages J, Koelmeyer L, Chen SL, et al
ASO Visual Abstract: Timing of Breast Cancer-Related Lymphedema Development Over 3 Years: Observations from a Large, Prospective Randomized Screening Trial Comparing Bioimpedance Spectroscopy (BIS) Versus Tape Measure.
Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15906.
PubMed

PRATT CG, Whitrock JN, Carter MM, Long SA, et al
ASO Visual Abstract: Implementation of Choosing Wisely(c) Recommendations for Lymph Node Surgery in Male Breast Cancer.
Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15924.
PubMed

MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
Financial Toxicity Among Women with Breast Cancer Varies by Age and Race.
Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15895.
PubMed Abstract available

HU J, Lu L
ASO Author Reflections: Significance of Predicting Omental Insufficiency in Breast Cancer Patients Receiving Immediate Breast Reconstruction with Pedicled Omental Flap After Mastectomy.
Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15958.
PubMed

LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
ASO Visual Abstract: Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Patients with Inflammatory Breast Cancer After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15919.
PubMed

BELLINI A, Keegan THM, Li Q, Maguire FB, et al
ASO Visual Abstract: Disparities in the Occurrence of Long-Term Effects of Bone Marrow Suppression after Treatment in Adolescent Young Adult Breast Cancer Survivors.
Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15912.
PubMed

MATTAR A, Antonini M, Amorim A, Mateus EF, et al
PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer.
Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15833.
PubMed Abstract available

CHENG O, Postlewait LM
ASO Author Reflections: Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15940.
PubMed

HUA T, Mendoza S, McCririe-Balcom M, Kelley J, et al
ASO Visual Abstract: Routine Clinical Breast Examination is a Low-Yield Practice Among Women at High Risk of Breast Cancer.
Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15914.
PubMed

MATTAR A
ASO Author Reflection: Reevaluating the Role of Preoperative MRI in Breast Cancer Surgery: Lessons Learned and Future Directions.
Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15925.
PubMed

LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
ASO Author Reflections: Time to Explore Minimally Invasive Axillary Nodal Staging After Neo-Adjuvant Chemotherapy in Inflammatory Breast Cancer.
Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15856.
PubMed Abstract available

DOLL A, Lipsyc-Sharf M, Sim MS, Baker JL, et al
ASO Visual Abstract: Outcome of Patients with Pregnancy-Associated Breast Cancer Who Have Subsequent Pregnancies.
Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15918.
PubMed

HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
Ann Surg Oncol. 2024 Jul 26. doi: 10.1245/s10434-024-15757.
PubMed Abstract available

CORTINA CS
ASO Author Reflections: A Breast Cancer Risk Assessment and the Decision for Gender-Affirming Chest Masculinization Surgery or Oncologic Risk-Reducing Mastectomies in Transgender and Gender-Diverse Individuals.
Ann Surg Oncol. 2024 Jul 26. doi: 10.1245/s10434-024-15801.
PubMed

FERRUCCI M, Passeri D, Milardi F, Montagna G, et al
ASO Author Reflections: Breast Cancer in Patients Aged >/= 90 Years: Surgery or No Surgery-This Is the Question.
Ann Surg Oncol. 2024 Jul 26. doi: 10.1245/s10434-024-15885.
PubMed

WANIS KN, Goetz L, So A, Glencer AC, et al
The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer.
Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15712.
PubMed Abstract available

MACCALLUM C, Elder K, Nickson C, Ruecker K, et al
Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer.
Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15848.
PubMed Abstract available

DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15876.
PubMed Abstract available

SWITALLA KM, Boughey JC, Mukhtar RA
ASO Author Reflections: Evolving Paradigms in Axillary Management for Breast Cancer: Insights from the ISPY-2 Neoadjuvant Chemotherapy Trial.
Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15873.
PubMed

HU J, Deng X, Li L, Liu H, et al
The Predictive Factors of Combined Implant Application for Breast Cancer Patients Receiving Immediate Breast Reconstruction with a Pedicled Omental Flap.
Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15882.
PubMed Abstract available

MOORE AM, Caudle AS, Sun SX, Yi M, et al
Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection.
Ann Surg Oncol. 2024 Jul 23. doi: 10.1245/s10434-024-15797.
PubMed Abstract available

LEE EG, Lee DE, Jung SY, Han JH, et al
Correction: ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024 Jul 23. doi: 10.1245/s10434-024-15901.
PubMed

DOLL A, Kapoor NS
ASO Author Reflections: First Descriptions of Patients with Pregnancy Associated Breast Cancer and Subsequent Pregnancy.
Ann Surg Oncol. 2024 Jul 23. doi: 10.1245/s10434-024-15854.
PubMed

STRIJBOS BTM, Janssen L, Voogd AC, Zwaans WAR, et al
ASO Author Reflections: Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors.
Ann Surg Oncol. 2024 Jul 21. doi: 10.1245/s10434-024-15855.
PubMed

LIMBERG JN, Thomas SM, Dalton JC, Ntowe KW, et al
Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia.
Ann Surg Oncol. 2024 Jul 21. doi: 10.1245/s10434-024-15788.
PubMed Abstract available

GLENCER AC, Wanis KN, Brown S, Lucci A, et al
Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities.
Ann Surg Oncol. 2024 Jul 21. doi: 10.1245/s10434-024-15713.
PubMed Abstract available

PRATT CG, Whitrock JN, Carter MM, Long SA, et al
Implementation of Choosing Wisely((R)) Recommendations for Lymph Node Surgery in Male Breast Cancer.
Ann Surg Oncol. 2024 Jul 20. doi: 10.1245/s10434-024-15811.
PubMed Abstract available

STRIJBOS BTM, Janssen L, Voogd AC, Zwaans WAR, et al
ASO Visual Abstract: Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors.
Ann Surg Oncol. 2024 Jul 18. doi: 10.1245/s10434-024-15850.
PubMed

GLENCER AC, Hunt KK, Teshome M
ASO Author Reflections: Management of Inflammatory Breast Cancer: No Role for Surgical De-escalation Yet.
Ann Surg Oncol. 2024 Jul 17. doi: 10.1245/s10434-024-15806.
PubMed

LIMBERG JN, Hwang ES
ASO Author Reflections: Trajectory of Subsequent Breast Cancer After Breast Atypia Diagnosis Suggests Need for Vigilant Follow-up.
Ann Surg Oncol. 2024 Jul 17. doi: 10.1245/s10434-024-15869.
PubMed

KRECKO LK, Neuman HB, Greenberg CC, Wilke LG, et al
ASO Visual Abstract: Validation of the AJCC Eighth-Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01).
Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15620.
PubMed

DALTON JC, Crowell KA, Ntowe KW, van den Bruele AB, et al
Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer.
Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15812.
PubMed Abstract available

BELLINI A, Keegan THM, Li Q, Maguire FB, et al
Disparities in the Occurrence of Long-Term Effects of Bone Marrow Suppression after Treatment in Adolescent Young Adult Breast Cancer Survivors.
Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15707.
PubMed Abstract available

MUNCK F, Jensen MB, Vejborg I, Gerlach MK, et al
ASO Visual Abstract: Residual Axillary Metastases in Node-Positive Breast Cancer Patients After Neoadjuvant Treatment-A Register-Based Study.
Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15752.
PubMed

IWAI Y, Perez-Rojas S, Thomas SM, Tadros AB, et al
ASO Visual Abstract: Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.
Ann Surg Oncol. 2024 Jul 15. doi: 10.1245/s10434-024-15691.
PubMed

BHIMANI F, Feldman S, Cavalli A, Chen Y, et al
ASO Visual Abstract: Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.
Ann Surg Oncol. 2024 Jul 15. doi: 10.1245/s10434-024-15832.
PubMed

TORTORELLO GN, Shafique N, Keele L, Susman CG, et al
Longitudinal Increases in Time to Surgery for Patients with Breast Cancer: A National Cohort Study.
Ann Surg Oncol. 2024 Jul 13. doi: 10.1245/s10434-024-15723.
PubMed Abstract available

PARK KU, Showalter SL, Dirbas FM
Surgical Perspectives on the Updated ASTRO Guideline on Partial Breast Irradiation for Breast Cancer.
Ann Surg Oncol. 2024 Jul 13. doi: 10.1245/s10434-024-15639.
PubMed Abstract available

SWITALLA KM, Boughey JC, Dimitroff K, Yau C, et al
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
Ann Surg Oncol. 2024 Jul 12. doi: 10.1245/s10434-024-15792.
PubMed Abstract available

BELLINI A, Sauder CAM
ASO Author Reflections: Disparities Exist for Adolescent Young Adult Breast Cancer Survivors.
Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15803.
PubMed

CARROLL JF, Hoskin TL, Hieken TJ
Correlation of PET-CT Nodal Imaging and Pathologic Response to Neoadjuvant Immunotherapy for Node-Positive Breast Cancer.
Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15826.
PubMed

DOLL A, Lipsyc-Sharf M, Sim MS, Baker JL, et al
Outcome of Patients with Pregnancy-Associated Breast Cancer Who Have Subsequent Pregnancies.
Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15798.
PubMed Abstract available

NTOWE KW, Thomas SM, Dalton JC, Olunuga E, et al
Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.
Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15793.
PubMed Abstract available

BOTTY VAN DEN BRUELE A, Weiss A
Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.
Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15638.
PubMed

CHEUN JH, Chung S, Han JH, Lee YW, et al
Surveillance for Distant Metastasis in Breast Cancer Patients Who Underwent Contemporary Management: A Report from the Korean Breast Cancer Society Survivor Research Group.
Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15665.
PubMed Abstract available

DI LENA E, Iny E, Wong SM, Bassel M, et al
Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.
Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15716.
PubMed Abstract available

SHAH C, Boyages J, Koelmeyer L, Chen SL, et al
Timing of Breast Cancer Related Lymphedema Development Over 3 Years: Observations from a Large, Prospective Randomized Screening Trial Comparing Bioimpedance Spectroscopy (BIS) Versus Tape Measure.
Ann Surg Oncol. 2024 Jul 4. doi: 10.1245/s10434-024-15706.
PubMed Abstract available

BHIMANI F, Feldman S, McEvoy M
ASO Author Reflections: Evaluating the Effectiveness of Axillary Reverse Mapping in Reducing Breast Cancer-Related Lymphedema Among Ethnically Diverse Patients.
Ann Surg Oncol. 2024 Jul 4. doi: 10.1245/s10434-024-15663.
PubMed

BEAULIEU-JONES BR, Ha EJ, Fefferman A, Wang J, et al
ASO Visual Abstract: Association of Race, Ethnicity, Language and Insurance and Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital.
Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15647.
PubMed

HUA T, Mendoza S, McCririe-Balcom M, Kelley J, et al
Routine Clinical Breast Examination Is a Low-Yield Practice Among Women at High Risk of Breast Cancer.
Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15702.
PubMed Abstract available

MCINTOSH SA, Mactier M, Fairhurst K, Gath J, et al
ASO Visual Abstract: Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer.
Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15683.
PubMed

MISHRA A, Deo SVS, Kumar N, Bansal B, et al
ASO Visual Abstract: A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low-Middle Income Country.
Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15696.
PubMed

SHEN A, Qiang W, Zhao H, Han G, et al
Contemporaneous Symptom Networks of Breast Cancer-Related Upper Limb Lymphedema: A Network Analysis.
Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15676.
PubMed Abstract available

KING TA, Mittendorf EA
Breast Articles From 2023: Informing Practice Across the Continuum of Care.
Ann Surg Oncol. 2024;31:4470-4476.
PubMed Abstract available

SETO Y, Ishitobi M, Nakayama T
ASO Author Reflections: Do Patients with Ipsilateral Breast Tumor Recurrence Prefer Repeat Breast-Conserving Surgery or Mastectomy?
Ann Surg Oncol. 2024;31:4540.
PubMed

SETO Y, Ishitobi M, Shien T, Oshiro C, et al
Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.
Ann Surg Oncol. 2024;31:4512-4517.
PubMed Abstract available

KIM M, Gilliland JL, Parnes MF, Bruce C, et al
BREAST-Q REACT: Qualitative Assessment of the Design, Functionality, and Clinical Utility of a New Score Interpretation Tool.
Ann Surg Oncol. 2024;31:4498-4511.
PubMed Abstract available

CHU JJ, Tadros AB, Vingan PS, Assel MJ, et al
ASO Visual Abstract: Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early Symptoms Predict 30-Day Surgical Complications.
Ann Surg Oncol. 2024;31:4547-4548.
PubMed

June 2024

JONNALAGADDA P, Rahurkar S
ASO Author Reflections: Disparities in Triple-Negative Breast Cancer Care: Are Some Patients Being Overlooked?
Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15640.
PubMed

PILEWSKIE M, Eroglu I, Sevilimedu V, Le T, et al
Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development.
Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15633.
PubMed Abstract available

STRIJBOS BTM, Janssen L, Voogd AC, Zwaans WAR, et al
Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors.
Ann Surg Oncol. 2024 Jun 28. doi: 10.1245/s10434-024-15682.
PubMed Abstract available

CORTINA CS, Purdy A, Brazauskas R, Stachowiak SM, et al
The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial.
Ann Surg Oncol. 2024 Jun 28. doi: 10.1245/s10434-024-15701.
PubMed Abstract available

LEE EG, Lee DE, Jung SY, Han JH, et al
ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024 Jun 24. doi: 10.1245/s10434-024-15580.
PubMed

JUNG JJ, Moon HG
ASO Author Reflections: Contralateral Axillary Metastasis in Breast Cancer: Prognostic Variability and Benefits of Surgical Treatment.
Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15440.
PubMed

IWAI Y, Perez-Rojas S, Thomas SM, Tadros AB, et al
Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.
Ann Surg Oncol. 2024 Jun 17. doi: 10.1245/s10434-024-15540.
PubMed Abstract available

CARROLL JF, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
Ann Surg Oncol. 2024 Jun 13. doi: 10.1245/s10434-024-15583.
PubMed Abstract available

LEE EG, Lee DE, Jung SY, Han JH, et al
ASO Visual Abstract: Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
Ann Surg Oncol. 2024 Jun 12. doi: 10.1245/s10434-024-15482.
PubMed

MISHRA A, Deo SVS, Kumar N, Bansal B, et al
A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low- to Middle-Income Country.
Ann Surg Oncol. 2024 Jun 11. doi: 10.1245/s10434-024-15527.
PubMed Abstract available

BHIMANI F, Feldman S, Cavalli A, Chen Y, et al
Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.
Ann Surg Oncol. 2024 Jun 6. doi: 10.1245/s10434-024-15577.
PubMed Abstract available

JUNG JJ, Cheun JH, Kang E, Shin I, et al
ASO Visual Abstract: Survival After the Contralateral Axillary Metastasis in Breast Cancer.
Ann Surg Oncol. 2024 Jun 6. doi: 10.1245/s10434-024-15546.
PubMed

GILMORE RC, Fine RE
Reply to: Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
Ann Surg Oncol. 2024 Jun 5. doi: 10.1245/s10434-024-15502.
PubMed

MYERS SP, Sevilimedu V, Jones VM, Abuhadra N, et al
ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
Ann Surg Oncol. 2024 Jun 4. doi: 10.1245/s10434-024-15491.
PubMed

KRECKO LK, Neuman HB, Greenberg CC, Wilke LG, et al
Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01).
Ann Surg Oncol. 2024 Jun 2. doi: 10.1245/s10434-024-15477.
PubMed Abstract available

CHAUHAN H, Ashrafian H, Takats Z, Leff DR, et al
ASO Author Reflections: The Impact of DCIS on Positive Margin Rates.
Ann Surg Oncol. 2024;31:3948-3949.
PubMed

CHAUHAN H, Jiwa N, Nagarajan VR, Thiruchelvam P, et al
Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery.
Ann Surg Oncol. 2024;31:3939-3947.
PubMed Abstract available

CARROLL MC, Yen RW, Leech M, Barth RJ Jr, et al
A Systematic Review and Meta-analysis of the Role of Preoperative MRI in In-breast Tumor Recurrence After Breast-Conserving Surgery.
Ann Surg Oncol. 2024;31:3926-3938.
PubMed Abstract available

VINGAN PS, Serafin J, Boe L, Zhang KK, et al
Reducing Disparities: Regional Anesthesia Blocks for Mastectomy with Reconstruction Within Standardized Regional Anesthesia Pathways.
Ann Surg Oncol. 2024;31:3684-3693.
PubMed Abstract available

GONZALEZ L, Johnson NC, Jones VC, Taylor L, et al
An Observational Cohort Study Comparing Positive Margin Rates Using an Electromagnetic Navigational System Versus Wire Localization in Breast Conservation Surgery.
Ann Surg Oncol. 2024;31:3669-3671.
PubMed

KIM Y, Ganduglia-Cazaban C, Tamirisa N, Lucci A, et al
Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery.
Ann Surg Oncol. 2024;31:3649-3660.
PubMed Abstract available

The American Society of Breast Surgeons Official Proceedings, Volume XXV 2024 Annual Meeting Scientific Session Abstracts.
Ann Surg Oncol. 2024;31.
PubMed

May 2024

SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
Racial Disparities in Breast Cancer Genetic Testing May be Mitigated by Counseling.
Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15434.
PubMed Abstract available

SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
ASO Visual Abstract: Racial Disparities in Breast Cancer Genetic Testing may be Mitigated by Counseling.
Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15536.
PubMed

NG TP, Loo BYK, Yong N, Chia CLK, et al
ASO Visual Abstract: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A Meta-analysis of Randomised Controlled Trials and Prospective Studies Comparing Use of Acellular Dermal Matrix (ADM) Versus Without ADM.
Ann Surg Oncol. 2024 May 23. doi: 10.1245/s10434-024-15446.
PubMed

MYERS SP, Downs-Canner SM
ASO Author Reflections: Immune-Related Adverse Events During Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer May Influence Time to Adjuvant Radiation.
Ann Surg Oncol. 2024 May 22. doi: 10.1245/s10434-024-15445.
PubMed

MCINTOSH SA, Mactier M, Fairhurst K, Gath J, et al
Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer.
Ann Surg Oncol. 2024 May 21. doi: 10.1245/s10434-024-15459.
PubMed Abstract available

ROACH EA, Weil CR, Cannon G, Grant J, et al
ASO Visual Abstract: The Role of Axillary Lymph Node Dissection Versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b-N3c Disease Who Receive Adjuvant Radiotherapy.
Ann Surg Oncol. 2024 May 20. doi: 10.1245/s10434-024-15419.
PubMed

MYERS SP, Sevilimedu V, Jones VM, Abuhadra N, et al
Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
Ann Surg Oncol. 2024 May 20. doi: 10.1245/s10434-024-15359.
PubMed Abstract available

PARVEZ E, Bogach J, Kirkwood D, Pond G, et al
ASO Visual Abstract: Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis.
Ann Surg Oncol. 2024 May 11. doi: 10.1245/s10434-024-15376.
PubMed

NGUYEN CL, Cui R, Zhou M, Ali F, et al
ASO Visual Abstract: Cost-Effectiveness of Radar Localization Versus Wire Localization for Wide Local Excision of Non-palpable Breast Cancer.
Ann Surg Oncol. 2024 May 9. doi: 10.1245/s10434-024-15383.
PubMed

LEE EG, Lee DE, Jung SY, Han JH, et al
Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15317.
PubMed Abstract available

HAMID SA, Schultz KS, Greenup RA
ASO Author Reflections: "Peace of Mind" After Surgery for Breast Cancer: Implications for Preference-Sensitive Shared Decision Making.
Ann Surg Oncol. 2024 May 7. doi: 10.1245/s10434-024-15408.
PubMed

PFOB A, Kokh DB, Surovtsova I, Riedel F, et al
Oncologic Outcomes for Different Axillary Staging Techniques in Patients with Nodal-Positive Breast Cancer Undergoing Neoadjuvant Systematic Treatment: A Cancer Registry Study.
Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15292.
PubMed Abstract available

NIJVELDT JJ, Rajan KK, Boersma K, Noorda EM, et al
ASO Visual Abstract: Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer-A Retrospective Analysis.
Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15375.
PubMed

MUNCK F, Jensen MB, Vejborg I, Gerlach MK, et al
Residual Axillary Metastases in Node-Positive Breast Cancer Patients After Neoadjuvant Treatment: A Register-Based Study.
Ann Surg Oncol. 2024 May 4. doi: 10.1245/s10434-024-15354.
PubMed Abstract available

JUNG JJ, Cheun JH, Kang E, Shin I, et al
Survival After Contralateral Axillary Metastasis in Breast Cancer.
Ann Surg Oncol. 2024 May 2. doi: 10.1245/s10434-024-15370.
PubMed Abstract available

GREENE AJE, Davis J, Moon J, Dubin I, et al
Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
Ann Surg Oncol. 2024;31:3177-3185.
PubMed Abstract available

CHU JJ, Tadros AB, Vingan PS, Assel MJ, et al
Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early Symptoms Predict 30-Day Surgical Complications.
Ann Surg Oncol. 2024;31:3377-3386.
PubMed Abstract available

April 2024

KAUFMAN C, Sarantou T, Donovan C, Kamali Polat A, et al
ASO Author Reflections: Increasing Time of Diagnosis to Breast Cancer Surgery.
Ann Surg Oncol. 2024 Apr 29. doi: 10.1245/s10434-024-15295.
PubMed

ROACH EA, Weil CR, Cannon G, Grant J, et al
The Role of Axillary Lymph Node Dissection versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b-N3c Disease Who Receive Adjuvant Radiotherapy.
Ann Surg Oncol. 2024 Apr 22. doi: 10.1245/s10434-024-15280.
PubMed Abstract available

PARVEZ E, Bogach J, Kirkwood D, Pond G, et al
Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis.
Ann Surg Oncol. 2024 Apr 18. doi: 10.1245/s10434-024-15250.
PubMed Abstract available

XIONG M, Young AT, Fernandez A, Jones JS, et al
Understanding Breast Cancer Surgery Through Tiktok: an Analysis of Video Content and Viewer Engagement.
Ann Surg Oncol. 2024 Apr 9. doi: 10.1245/s10434-024-15268.
PubMed Abstract available

QIU M, Liang F, Xie Y, Yang H, et al
Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction: A Prospective Study of Initial 68 Procedures.
Ann Surg Oncol. 2024;31:2777-2785.
PubMed Abstract available

WESTENEND P, Meurs C, van Bekkum S, van Rosmalen J, et al
ASO Author Reflections: What Can Prediction Models for Upstaging of DCIS Diagnosed on Biopsy Tell Us About DCIS Surveillance Trials?
Ann Surg Oncol. 2024;31:2272-2273.
PubMed

EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
ASO Visual Abstract: Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy-Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
Ann Surg Oncol. 2024;31:2276-2277.
PubMed

SINGH P, Agnese D, Amin M, Barrio AV, et al
Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks.
Ann Surg Oncol. 2024;31:2212-2223.
PubMed Abstract available

RUBENSTEIN RN, Kim M, Plotsker EL, Chu JJ, et al
Early Complications in Prepectoral Tissue Expander-Based Breast Reconstruction.
Ann Surg Oncol. 2024;31:2766-2776.
PubMed Abstract available

QIU M, Liang F, Xie Y, Yang H, et al
ASO Author Reflections: A Novel Technique of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction.
Ann Surg Oncol. 2024;31:2791-2792.
PubMed

POLIDORIO N, Montagna G, Sevilimedu V, Le T, et al
Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?
Ann Surg Oncol. 2024;31:2231-2243.
PubMed Abstract available

QIU M, Liang F, Xie Y, Yang H, et al
ASO Visual Abstract: Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction-A Prospective Study of Initial 68 Procedures.
Ann Surg Oncol. 2024;31:2794-2795.
PubMed

EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
Ann Surg Oncol. 2024;31:2224-2230.
PubMed Abstract available

WIENER AA, Schumacher JR, Perlman SB, Wilke LG, et al
A Four-Arm Randomized Clinical Trial of Topical Pain Control for Sentinel Node Radiotracer Injections in Patients with Breast Cancer.
Ann Surg Oncol. 2024 Apr 1. doi: 10.1245/s10434-024-15235.
PubMed Abstract available

March 2024

SCODARI BT, Schaefer AP, Kapadia NS, Brooks GA, et al
The Association Between Oncology Outreach and Timely Treatment for Rural Patients with Breast Cancer: A Claims-Based Approach.
Ann Surg Oncol. 2024 Mar 27. doi: 10.1245/s10434-024-15195.
PubMed Abstract available

NIJVELDT JJ, Rajan KK, Boersma K, Noorda EM, et al
Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis.
Ann Surg Oncol. 2024 Mar 24. doi: 10.1245/s10434-024-15182.
PubMed Abstract available

NGUYEN CL, Cui R, Zhou M, Ali F, et al
Cost-Effectiveness of Radar Localisation Versus Wire Localisation for Wide Local Excision of Non-palpable Breast Cancer.
Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15142.
PubMed Abstract available

CHUNG AP, Dang CM, Karlan SR, Amersi FF, et al
ASO Visual Abstract: A Prospective Study of Sentinel Node Biopsy Omission in Women Age >/= 65 with ER+ Breast Cancer.
Ann Surg Oncol. 2024 Mar 6. doi: 10.1245/s10434-024-15137.
PubMed

COSTARELLI L, Arienzo F, Broglia L, La Pinta M, et al
Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?
Ann Surg Oncol. 2024 Mar 1. doi: 10.1245/s10434-024-15052.
PubMed Abstract available

February 2024

JAKUB JW, Advani P, Maxwell R, Vallow L, et al
SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We Ready to Change the Tune of Our Breast Cancer Practice?
Ann Surg Oncol. 2024 Feb 28. doi: 10.1245/s10434-024-15111.
PubMed

November 2023

SETO A, Pass A, Babkowski R, Volpicelli ER, et al
Routine Use of a Standardized Mastectomy Diagram by Surgeons Improves Accuracy and Timeliness of the Final Pathological Report.
Ann Surg Oncol. 2023;30:7124-7130.
PubMed Abstract available

FRANCO I, Alshalalfa M, Hernandez A, Mahal BA, et al
Genomic Characterization of Aggressive Breast Cancer in Younger Women.
Ann Surg Oncol. 2023;30:7569-7578.
PubMed Abstract available

MEURS CJC, van Bekkum S, van Rosmalen J, Menke-Pluijmers MBE, et al
Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ.
Ann Surg Oncol. 2023;30:7069-7080.
PubMed Abstract available

ZAVERI S, Everidge S, FitzSullivan E, Hwang R, et al
Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection.
Ann Surg Oncol. 2023;30:7015-7025.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum